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ABSTRACT 
Introduction: Over half of breast cancer survivors living in the United States are overweight or 
obese at the time of their diagnosis. Metabolic syndrome (MetS) is a clustering of risk factors 
linked to insulin resistance that has important long-term health implications for breast cancer 
survivors.  Fasting insulin is associated with breast cancer recurrence and death; however, 
postprandial measures may be better indicators of insulin resistance among breast cancer 
survivors.  Weight management through diet and physical activity play an important role in 
improving insulin sensitivity and MetS in the general population, but less is known about these 
effects among breast cancer survivors. Furthermore, sedentary behavior is a growing problem 
among the general population and breast cancer survivors alike.  Little research has been done to 
determine effective ways to reduce sedentary behavior and barriers to sitting less are not well 
understood.   The goals of this project were to 1) assess the impact of weight loss and weight loss 
maintenance on components of MetS among obese and overweight breast cancer survivors, 2) 
determine relationships between changes in dietary and physical activity variables and changes 
in the components of MetS, 3) examine changes in fasting and postprandial glucose and insulin, 
and measures of insulin resistance following the same weight management intervention among 
breast cancer survivors, 4) determine if change in weight, dietary intake or physical activity are 
predictors of improvements in insulin sensitivity after a weight management intervention, 5) 
assess barriers to reduce sedentary behavior within a weight maintenance intervention among 
breast cancer survivors.  Methods:  Twenty-four obese and overweight women were recruited 
and enrolled in a 10 month weight management intervention and 22 participants completed the 
study. Phase one (baseline – 4 months) focused on weight loss through reduced caloric intake 
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and increased physical activity. Phase two (4 months – 10 months) focused on weight loss 
maintenance.  During phase two, participants were randomized to receive our standard weight 
loss maintenance program (MAINT) or to the same weight maintenance program with an added 
intervention aimed to reduce sedentary behavior (MAINT + SED).  The MAINT + SED received 
technology-based tools for tracking weight, diet and physical activity. Assessment visits took 
place at baseline, 4 months and 10 months. At each time point, anthropometric measurements 
were completed and fasting blood samples were collected.  Participants were fed a standardized 
meal at each time point and five subsequent blood samples were collected at 30 minutes, 45 
minutes, 60 minutes, 90 minutes, and 120 minutes post meal.  MetS components (waist 
circumference, blood pressure, high density lipoprotein cholesterol (HDL-C), triglycerides, 
fasting glucose), fasting insulin, postprandial insulin as measured by total area under the curve 
and positive incremental area under the curve (AUC and iAUC), glucose (AUC and iAUC), and 
two surrogate measures of insulin resistance (HOMA-IR and Matsuda Index) were analyzed 
and/or calculated at baseline, 4 months and 10 months.    Self reported measures of diet (24 hour 
dietary recalls), moderate to vigorous physical activity (MVPA) (Modifiable Activity 
Questionnaire) and sedentary time (Multi-context Sitting Time Questionnaire) were assessed at 
each time point. Qualitative surveys based on the Theory of Planned Behavior were administered 
to participants in MAINT + SED to assess perceived barriers to reducing sitting time and 
satisfaction of technology.  Results:  After phase one, participants lost a mean of 10.7% ± 3.9% 
of their baseline weight and significantly reduced their waist circumference (-7.03 cm), fasting 
glucose (-7.14 mg/dl), triglycerides (-22.23 mg/dl) and HDL-C (-5.59 mg/dl). From baseline to 4 
months, fasting insulin decreased (-5.66 mU/l), postprandial insulin (AUC and iAUC) decreased 
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by 32% and 28% respectively, and insulin sensitivity significantly improved, as evidenced by a 
47% decrease in HOMA-IR and a 44% increase in Matsuda Index. The participants who lost the 
greatest percent of baseline weight at 4 months had the greatest decreases in waist circumference 
(r=0.67), decreases in percent calories from fat (r=0.52) and increases in fruit and vegetable 
intake(r=-0.54).  During phase two, participants successfully maintained their weight loss and 
waist circumference further decreased (-2.76 cm) and HDL-C increased (+11.82 mg/dl).  
Postprandial insulin (AUC and iAUC), HOMA-IR, and Matsuda Index scores did not 
significantly change from 4 to 10 months. Dietary changes, MVPA changes and sedentary time 
changes were not predictive of changes in fasting insulin or changes in insulin sensitivity.  
Percent weight loss from baseline to 10 months was not significantly related to changes in 
fasting insulin (r=0.32) or HOMA-IR (r=0.27) from baseline to 10 months. However, changes in 
Matsuda Index scores were correlated with percent weight loss from baseline to 10 months (r=-
0.545).  Furthermore, participants in the MAINT + SED arm were not able to successfully reduce 
their sedentary time during the maintenance phase.  Perceived barriers to reducing sitting time 
included perceived lack of control over changing their sitting behaviors at the workplace.  
Conclusion:  The 10 month weight management intervention successfully improved components 
of metabolic syndrome and insulin sensitivity among overweight and obese breast cancer 
survivors. Reducing sedentary time within a weight maintenance intervention was unsuccessful 
and the most important perceived barriers were workplace activities.  Future interventions should 
focus on identifying effective lifestyle strategies to alleviate metabolic syndrome and insulin 
resistance among breast cancer survivors on a larger scale.  Feasible strategies to reduce 
sedentary time should also be identified in this high-risk group. 
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OBESITY AMONG BREAST CANCER SURVIVORS 
Breast cancer survivors make up the largest percent (22%) of all cancer survivors in the 
United States (1). The term cancer survivor is defined by the Centers for Disease Control and 
Prevention (CDC) as beginning at the time of cancer diagnosis and spanning throughout the 
entirety of life(1). Cancer survivorship includes the physical, psychosocial, and economic issues 
of cancer and their impact on the survivor and the family, friends and caregivers of the survivor 
(2).  The number of cancer survivors continues to grow as diagnostic strategies improve and 
treatments advance.  Concurrently, the breadth of survivorship care is expanding and the 
examination of risk factors for recurrence and other co-morbidities among this high-risk group 
are mounting areas of research.  
In the United States, 20% of cancer mortality among women can be attributed to obesity 
(3). This is especially problematic for breast cancer survivors, of whom 50% are overweight or 
obese the time of diagnosis (4, 5).  Breast cancer survivors who are obese or overweight at the 
time of diagnosis have 40% higher risk of recurrence and mortality when compared to normal 
weight survivors (6, 7). In addition, breast cancer survivors commonly gain weight after 
diagnosis (8). A weight gain of 6-10 kg is associated with increased risk of cancer recurrence and 
death from breast cancer (9).  Post-diagnosis weight gain is due to a variety of hormonal and 
lifestyle factors including the effects of chemotherapy, antihormone therapy, increased energy 
intake, and decreases in physical activity following diagnosis (10).  Considerable evidence links 
both obesity and post-diagnosis weight gain with increased risk of recurrence, death from breast 
cancer and all-cause mortality (6, 9, 11, 12).    
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METABOLIC DYSFUNCTION AND BREAST CANCER SURVIVORSHIP 
Metabolic syndrome (MetS) is a grouping of risk factors associated with obesity that 
impacts the health and longevity of breast cancer survivors (13).   The concept of MetS was first 
introduced in 1988 by Dr. Gerald Reaven, an endocrinologist at Stanford University, as a 
syndrome linking central obesity, elevated circulating free fatty acids, and hypertension to the 
underlying presence of insulin resistance (14).    However, it was not until 1998, that the World 
Health Organization (WHO) formally defined the syndrome as a clustering of metabolic markers 
based on insulin resistance (15). Since then, a joint interim statement of the International 
Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and 
Blood Institute; American Heart Association; World Heart Federation; International 
Atherosclerosis Society; and International Association for the Study of Obesity, states the 
combination of any three or more of the following criteria indicates diagnosis of MetS: elevated 
fasting glucose (≥ 100 mg/dl) or pharmacologic treatment for hyperglycemia; central adiposity 
(≥ 88cm for women); elevated serum triglycerides (≥ 150 mg/dl) or pharmacologic treatment for 
elevated triglycerides; low levels of high density lipoprotein cholesterol (HDL-C) (<50 mg/dl for 
women) or pharmacologic treatment for elevated HDL-C; and elevated blood pressure (systolic ≥ 
130 mm Hg and/or diastolic ≥ 85 mm Hg) or antihypertensive drug treatment (16).  
A recent meta-analysis of 9 studies determined MetS is associated with 52% increased 
risk of developing breast cancer in post-menopausal women (17).  In each of the studies included 
in the meta-analysis, the full syndrome explained a greater risk of breast cancer than each of the 
individual criteria of MetS, suggesting MetS is most predictive of breast cancer when viewed as 
a whole condition (17).  Nonetheless, the individual criteria play an important role in the health 
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of breast cancer survivors. In one recently published study, 2092 breast cancer survivors were 
followed for 2.8 years and breast cancer related outcomes and MetS criteria were documented.  
The authors found that all components of the MetS were individually associated with increased 
risk of breast cancer events; however, only HDL-C and triglycerides conferred statistically 
significant risk (18). Women who had MetS were more likely to have a breast cancer recurrence 
or new primary diagnosis (adjusted OR: 2.17) or breast cancer metastasis (adjusted OR: 2.45) 
when compared to those who did not have MetS. 
The implications of MetS are not only important for prevention of breast cancer 
recurrence, but are also key in the prevention of other chronic diseases and co-morbidities among 
breast cancer survivors.  Breast cancers survivors with MetS have increased risk of 
cardiovascular disease, type 2 diabetes and death (19, 20).  This is important because MetS 
confers a fourfold increased risk for type 2 diabetes and a twofold increased risk of 
cardiovascular disease in the general population (16). Furthermore, older breast cancer survivors 
diagnosed with early stage breast cancer are more likely to die of cardiovascular disease than 
breast cancer recurrence (21).  
Weight loss through diet and exercise alleviates all components of MetS. The National 
Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) recommends 
Therapeutic Lifestyle Change (TLC) through weight loss and increased physical activity as the 
first line of treatment for MetS (22). Pharmacologic treatment for individual components of 
MetS is recommended after 6 weeks of unsuccessful TLC.  Cancer specific recommendations 
from the American Cancer Society and the World Cancer Research Fund are aimed at reducing 
the risk of recurrence and all-cause mortality, including achieving and maintaining a healthy 
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weight, eating a diet high in fruits and vegetables and engaging in regular physical activity (23).  
However, the majority of cancer survivors are not meeting weight, diet or physical activity 
recommendations (24, 25).  For these reason, weight management interventions have been a 
major focus in survivorship research.  
 
WEIGHT MANAGEMENT AMONG BREAST CANCER SURVIVORS 
Several weight management interventions have achieved successful weight loss among 
breast cancer survivors (26-33); however, very few interventions have examined long-term 
maintenance of weight loss and its subsequent impact on recurrence. Weight loss has ranged 
from 3 to 12 kg in interventions lasting 6 months to one year, with the most successful 
interventions including a comprehensive lifestyle program including a cognitive behavioral 
approach (28, 33-37). Although long-term successful weight maintenance is crucial to achieve 
health benefits, very few trials follow-up beyond the intervention phase (38).  A recent large-
scale review of physical activity and diet intervention trials among breast cancer survivors 
indicated only 16% of the reviewed trials assessed long term (3-5 year) post-intervention 
measures and only 6% of reviewed trials indicated successful maintenance of behavioral 
interventions (39). Befort et al. are currently conducting a long-term maintenance trial (R01 
CA155014) designed to assess post intervention maintenance of weight loss in rural breast 
cancer survivors after a 6-month period of no contact (40).  Rock et al. has a similar project 
underway with goals to examine the effects of long-term post intervention weight maintenance 
on breast cancer recurrence (41).   
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Weight regain following a weight loss intervention is an ongoing challenge in 
commercial, clinical and research settings among the general population.  Among the trials 
examining maintenance of weight loss, 10-30% weight regain was observed over one year (42, 
43). In a survey of the National Weight Control Registry, 20% of over 4,000 individuals 
surveyed were successful maintainers, defined as losing 10% of their initial weight and 
sustaining the loss for at least one year.  The strongest predictor of weight loss maintenance is 
regular participation in moderate to vigorous physical activity (MVPA) (44, 45).  Other 
predictors of successful maintenance include diet consistency, regular self-monitoring of diet and 
exercise and breakfast consumption (45). Though the American Cancer Society recommends 150 
minutes of MVPA per week for cancer prevention (46), 225-300 minutes of MVPA are required 
to maintain weight loss (47). The effects of high MVPA recommendations on weight 
maintenance have not yet been replicated in well-powered trials; however, Donnelly and 
colleagues have a randomized controlled trial underway to examine the effectiveness of three 
different levels of MVPA in prevention of regain (48). While MVPA is one of the best predictors 
of weight regain, increasing MVPA is sometimes compensated for by a simultaneous increase in 
sitting time (49, 50). Thus, even individuals who participate in planned exercise may compensate 
by sitting more throughout their day (51).  
 
INSULIN AND BREAST CANCER   
Insulin is an anabolic peptide hormone that is secreted by the beta cells of the pancreas 
and plays an important role in glucose homeostasis and macronutrient metabolism (52). Insulin 
resistance is a condition in which the body’s ability to mediate glucose disposal is attenuated, 
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resulting in the need for greater levels of insulin production to maintain glucose homeostasis 
(14). Insulin possesses both metabolic and mitogenic effects that contribute to proliferation of 
malignant breast cells (53, 54).  The mechanisms underlying the connection between breast 
cancer risk and insulin are not well established, but several are postulated.  In vitro studies have 
demonstrated that insulin stimulates the proliferation of breast cancer cell lines (55, 56). 
Furthermore, animal models show exogenous insulin can induce mammary tumor growth (57).   
In humans, chronic hyperinsulinemia is associated with higher levels of ovarian estrogen 
production and increased circulating estradiol (58). Another potential mechanism involves the 
subsequent rise in insulin like growth factor-1 (IGF-1), a strong mitogenic signal in normal 
breast epithelial cells and hyperplasic breast cells (54).  In addition, breast cancer cells may 
overexpress the insulin receptor (59).   
Elevated fasting insulin has been associated with increased recurrence and mortality 
among breast cancer survivors (53, 60-62).  Two of three large prospective studies showed an 
association between increased fasting insulin and greater risk of breast cancer in postmenopausal 
women (54, 63).  However, one study showed no relationship between fasting insulin and risk of 
breast cancer in premenopausal women (64).  This may be related to the fact that in 
postmenopausal breast cancer, increased levels of bioavailable estrogens are from adipose tissue, 
whereas the primary source of estrogens in premenopausal women is the ovaries (65).   
 The connection between obesity, hyperinsulinemia and breast cancer has laid the 
groundwork for landmark studies targeting insulin modulation through weight loss among 
overweight and obese breast cancer survivors (66, 67).  Several intervention studies among 
breast cancer survivors show significant decreases in fasting insulin ranging from 17%-26% 
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following >5% loss of baseline weight (27, 31, 37). A few trials targeting physical activity 
among breast cancer survivors have observed a subsequent decrease (7-28%) in fasting insulin 
(68, 69).  However, not all trials targeting physical activity alone have observed a significant 
change in insulin levels in breast cancer survivors (70, 71).  The most convincing evidence 
among this population suggests weight loss through changes in diet and physical activity 
produces the greatest reductions in insulin. 
Significant improvements in insulin resistance as measured by homeostatic model 
assessment of insulin resistance (HOMA-IR) are evidenced in several weight management 
studies among breast cancer survivors (27, 31, 72).  Improvements in HOMA-IR scores have 
ranged from 21% - 26% in three 12-month interventions targeting diet and physical activity 
among overweight and obese breast cancer survivors (27, 31, 72).  One study assessing weight 
loss by way of two different diets (low carbohydrate vs. low fat) found no difference between 
arms in HOMA-IR scores, but a significant overall difference from baseline to 12 months in both 
dietary groups was observed after clinically significant weight loss was achieved (27).  The 
Nutrition and Exercise in Women (NEW) study compared the effect of diet only, exercise only, 
diet and exercise, and a control intervention on weight loss among postmenopausal women.  
They found the greatest difference in HOMA-IR scores in the diet and exercise group and the 
diet only group (72).  There was no significant change in HOMA-IR scores after one year in the 
exercise only group. However, the exercise only group did not lose as much weight as the other 
two groups, suggesting weight loss may have the principal impact on improved insulin 
sensitivity (72).     
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MEASURES OF INSULIN RESISTANCE  
 The gold standard for assessment of whole-body insulin sensitivity is measured through 
the hyperinsulinemic-euglycemic insulin clamp technique (73).   This method uses intravenous 
insulin to induce hyperinsulinemia and a glucose tracer to quantify site specific insulin resistance 
and their respective contributions to insulin-mediated glucose disposal (73).  The clamp method 
is time and labor intensive and is rarely used in large epidemiological studies and never used in 
clinical settings (74). A more common and less invasive assessment of insulin sensitivity and 
pancreatic beta cell function is a mathematical model utilizing fasting insulin and fasting glucose 
concentrations to calculate the aforementioned HOMA-IR (75).  The HOMA-IR model was 
originally described in 1985 by Matthews et al. in effort to assess hepatic glucose production and 
insulin secretion in the basal state (75).  HOMA-IR is equal to the product of fasting insulin 
(mU/l) and fasting glucose (mmol/l), divided by a constant, k, where k=22.5. HOMA-IR is 
highly correlated with the clamp (r=0.69) and is especially useful in assessing changes in insulin 
resistance in longitudinal studies (75, 76). However, HOMA-IR is limited to the fasting status of 
its components and thus cannot distinguish between hepatic and peripheral insulin sensitivity 
after a meal (77).  
 Although fasting measures of insulin resistance are clinically convenient, postprandial 
measures are stronger predictors of cardiovascular disease and all-cause mortality when 
compared to fasting measures (78-80).  Furthermore, oxidative stress is more strongly correlated 
with glucose excursions after a meal when compared to fasting measures of glycemic control 
(81). This is likely true because postprandial measures may be more sensitive to abnormalities in 
glycemic control that are not evident through fasting measures (74, 82). In the fasting state, tight 
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control is exhibited to maintain equal levels of glucose utilization and endogenous glucose 
production, namely through increased glucagon secretion and decreased insulin secretion (83).  
Also during the fasting state, insulin functions to inhibit hepatic glucose production and thereby 
promote glucose homeostasis. Therefore, fasting measures of glucose and insulin reflect tight 
homeostatic control in a state of energy conservation (84).  After a meal, glucose levels rise and 
insulin is secreted to coordinate the uptake of glucose by adipose, liver and muscle. It is possible 
to have apparently normal homeostatic control of fasting glucose and insulin, but dysfunctional 
regulation of glucose and insulin after a meal.  Additionally, the complexity of post meal 
glycemic control is more than the result of impaired pancreatic beta cells function.  Insulin 
resistance is also a manifestation of altered fat metabolism, incretin deficiency and resistance, 
increased hepatic sensitivity to glucagon, enhanced renal glucose absorption and impaired insulin 
utilization by the central nervous system (85).  
The Matsuda Index is a mathematical model estimating whole body insulin sensitivity 
that is highly correlated with the clamp method (r=0.73) (77).  This particular index is 
specifically useful in assessing whole body insulin sensitivity as it takes into account both fasting 
insulin, fasting glucose, mean postprandial insulin, and mean postprandial glucose (77).  The 
Matsuda Index was first developed as a method of measuring insulin sensitivity following the 
oral glucose tolerance test (OGTT) and was compared to several other indices of insulin 
resistance including the HOMA-IR method (77). The Matsuda Index has been strongly 
correlated with HOMA-IR in individuals with normal glucose tolerance (r=0.935) and 
individuals with impaired glucose tolerance (r=0.831) (77). The OGTT is used in clinical settings 
as a diagnostic tool in identifying impaired glucose tolerance and type 2 diabetes (78).  While the 
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OGTT has been widely used in research and clinical settings alike, there have been numerous 
studies questioning the physiological relevance of a 75 gram glucose load (86-88). Most free-
living individuals consume meals containing a mix of protein, fat, and carbohydrate. Although 
the Matsuda Index was first used with OGTT, Young and colleagues have successfully used the 
Matsuda Index to determine insulin resistance to a mixed meal (89).   
 Both HOMA-IR and Matsuda Index will be used in this dissertation as measures of 
insulin resistance.  The HOMA-IR method will use fasting insulin and glucose and the Matsuda 
Index will use both fasting and postprandial measures to assess insulin resistance.  The HOMA-
IR method has been used to identify insulin resistance in breast cancer survivors, whereas no 
published studies have used the Matsuda Index in this population. Postprandial measures are 
important for this population given the relationship between insulin and breast cancer pathways.  
 
SEDENTARY BEHAVIOR  
 The term sedentary originates from the Latin word sedere meaning to sit. Throughout this 
dissertation the term sedentary behavior will be used to describe any activity that includes sitting, 
reclining or laying and that requires a low level of energy expenditure, specifically between 1.0-
1.5 multiples of the basal metabolic rate (METS) (90) and is distinct from too little exercise (91, 
92). Sedentary behaviors encompass all time spent sitting during commutes, sitting throughout 
the workday, sitting during leisure time (including watching television), and sitting during 
domestic activities.  It is possible for a person to meet physical activity guidelines of 150 minutes 
per week and still spend the majority of their daily time sedentary (49, 50).   
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The average American adult spends over half of their daily waking hours in sedentary 
behaviors (approximately 8 hours per day) as measured by accelerometry data from the National 
Health and Nutrition Examination Survey (NHANES) (93).  The overall increase in sedentary 
behavior has changed drastically since the 1950’s with the decline of work-related activity, 
transportation-related activity and home-related activity and the increased use of technology 
(94).  Much of the current evidence regarding sedentary behavior of Americans has been focused 
on television time, especially among children and adolescents (95).  However, more recent 
research has examined the prevalence of workplace sitting and the time spent in front of screens 
other than televisions (91, 96).  
Emerging research indicates the overall increase in sedentary behavior is associated with 
significant health risks, including obesity (97), cardiovascular disease (98), type 2 diabetes (97, 
99), certain cancers (100) and all-cause mortality (101).  Katzmarzyk and colleagues observed a 
dose response between sitting time and death from all causes after adjusting for all potential 
confounding variables including MVPA, smoking and diet (102).  Numerous studies have shown 
the risk factors associated with sedentary behavior are independent of MVPA, suggesting sitting 
time may be just as important as MVPA in reducing health risks (103, 104).  
 
SEDENTARY BEHAVIOR AND BREAST CANCER  
 There is a substantial body of evidence in the form of both epidemiological and 
intervention studies, linking increased MVPA with reduced risk of breast cancer risk in both pre 
and post-menopausal women (105, 106).   The relationship between sedentary behavior and 
breast cancer risk was first introduced as a lack of MVPA; however, observational data suggest 
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there is an independent relationship between sedentary behavior and breast cancer risk (107). 
These risk factors are important because objectively measured data from the NHANES data 
shows breast cancer survivors spend 68% of their waking hours sedentary and less than 1% of 
waking hours doing MVPA (100).  
 There have been mixed results among the few observational studies examining sedentary 
behaviors and health related outcomes among breast cancer survivors. A cross sectional study 
revealed associations between objectively measured MVPA and sedentary behavior with 
established biomarkers of breast cancer risk, including body mass index (BMI), waist 
circumference, C-reactive protein, fasting insulin and HOMA-IR.  The same study also 
suggested that light intensity activity might play a protective role in breast cancer risk, 
independent of MVPA (105). Another cross sectional study indicated high levels of sedentary 
behavior was positively associated with breast cancer among a survey of 996 breast cancer 
patients and 1164 controls (odds ratio: 1.81) (107).   However, no relationship was observed 
between light intensity activity and breast cancer.   
The research revealing a connection between sedentary behavior and breast cancer risk 
has been observational in nature. Thus a recent review by Lynch et al. highlights the need for 
simple and effective interventions to decrease sedentary behavior among breast cancer survivors 
(100). No published research has attempted to decrease sedentary behavior within a weight 
management intervention. 
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INTERVENTIONS TARGETING SEDENTARY BEHAVIOR  
 Interventions targeting sedentary behavior among adults are limited and it is clear there is 
an impetus to create effective interventions to decrease sedentary behavior in prospective, long-
term studies (108). The field of sedentary behavior research is relatively new, and interventions 
targeting sedentary behavior in adults are limited.  One study by Gardiner et al. examined the 
feasibility of reducing sedentary time throughout the day and in multiple contexts in older adults 
through a single face-to-face consultation with study staff and subsequent tailored print materials 
reviewing each individual’s progress (109).  Gardiner reported a 3.2% decrease in overall 
sedentary time, increased breaks in sedentary time and high program satisfaction among 
participants from baseline to 2 weeks; however no other health outcomes were assessed nor did 
the study have long term follow up.  Another study among adults was successful in reducing 
overall TV time by use of a system that turned off the television after an allotted amount of time.  
There was a 61% reduction in TV time among the intervention group, with a 3.8% decrease in 
overall sedentary time when compared to the control group (110).  In addition to the reduction in 
TV time, the intervention group demonstrated a significant increase in energy expenditure when 
compared to the control group. 
 Three interventions have been conducted with the single goal of reducing sedentary 
behavior in the workplace. They report different effects based on whether sedentary time is 
measured via self-report or objectively through the use of accelerometers. Objectively measured 
sitting time was significantly reduced by 11% among overweight men and women in a 12 week 
internet-based intervention in the workplace (111). Another study using accelerometers also 
showed a modest but significant reduction (1.6%) in sitting time among Australian office 
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workers (112). A study assessing both self-reported changes and objective changes in sitting time 
found a significant 20% reduction in self-reported sitting time (-12.0 hours per week); however, 
there was no reduction in objectively measured sitting time (113).   
 A few studies have targeted MVPA and sedentary behavior in the same intervention and 
have reported a modest reduction in sedentary time (93, 110, 114). Studies that have targeted 
MVPA only have been less successful in reducing sedentary behavior. In fact, work by Befort et 
al. reported an increase in MVPA over a 6 month weight management intervention, but no 
significant differences in sedentary minutes, with a trend toward increasing sedentary time as 
measured by accelerometry (115). Therefore, it seems there must be interventions targeted 
specifically at reducing sedentary behavior in order to achieve meaningful changes in the 
sedentary behaviors of adults.  
 
INSULIN MODULATON AND SEDENTARY BEHAVIOR   
Reducing sedentary behavior may improve insulin sensitivity. Observational studies 
based on NHANES data have revealed a relationship between self-reported time spent sitting 
while watching television and fasting insulin in a group of over 2,000 adults living in the U.S. 
(116). Population based studies in the U.S. have shown significant associations between 
objectively measured sedentary time and waist circumference, insulin, insulin resistance, HDL-C 
and triglycerides (104, 117). A population based study in Australia showed similar associations 
between objectively measured sitting time and metabolic risk factors, including triglycerides and 
waist circumference (117).  
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The mechanisms explaining the link between sedentary behavior levels and insulin 
sensitivity may include a combination of genetic and physiologic factors by which the body 
acclimates to low levels of energy expenditure and promotes energy storage, increased adiposity 
and decreased muscle mass.  Much of the mechanistic understanding of the link between 
sedentary behavior and insulin resistance has been elucidated by studying the transition from low 
levels of activity to high levels of activity and vice versa (118). This includes, but is not limited 
to, decreased energy demands from skeletal muscles, decreased glucose uptake by skeletal 
muscle through decreased concentration and translocation of GLUT-4 (the primary glucose 
transporter in skeletal muscle which has high affinity for glucose) to skeletal muscle surface, and 
decreased levels of lipoprotein lipase (119, 120).  
Most of the evidence up to this point has shown significant associations between long 
periods of uninterrupted sedentary behavior and insulin, insulin sensitivity, and glucose 
tolerance.  One study by Stephens et al observed a 39% reduction in whole body insulin response 
after a 24-hour period of uninterrupted sitting (121). Research among individuals on bed rest 
revealed that up to 5 days of continuous bed rest resulted in increased fasting insulin, increased 
fasting glucose, increased triglycerides, increased LDL cholesterol and reduced insulin 
sensitivity (122). Similar work examining the effects of uninterrupted sedentary behavior has 
shown significantly reduced levels of lipoprotein lipase activity in skeletal muscle, an essential 
enzyme responsible for both metabolism and transport of lipids (92).    
Interrupting sitting time can obviate the effects of long bouts of uninterrupted sitting 
time. Frequent interruptions in sedentary time (the transition from sitting to an active state for 
approximately 4 minutes) were associated with favorable changes in cardiometabolic risk factors 
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such as improvements in 2-hour OGTT levels, and plasma triglycerides (120). Similarly, Dustan 
and colleagues conducted a tightly controlled three-arm crossover trial examining the effects 
uninterrupted sitting, sitting with 2 minute breaks of light intensity activity (leisure walking) 
every 20 minutes, or sitting with 2 minute breaks of moderate intensity walking (brisk walking) 
every 20 minutes on postprandial glucose and insulin levels.  They found that interrupting sitting 
time with light intensity or moderate intensity activity every 20 minutes resulted in significant 
improvements in postprandial glucose positive incremental area under the curve (iAUC) and 
postprandial insulin positive iAUC.  However, there was no difference between the light 
intensity and moderate intensity conditions, suggesting light intensity activity breaks are 
sufficient for producing beneficial changes in glucose and insulin modulation (123).   
 
CONCLUSION 
Obesity, metabolic syndrome, insulin resistance and sedentary behavior all appear to play 
a role in increasing the risk of breast cancer recurrence, co-morbidities, and death among breast 
cancer survivors.  Weight loss through lifestyle interventions improves MetS and insulin 
resistance in the general population.  Some studies among breast cancer survivors also show 
promising outcomes in components of MetS, fasting measures of insulin and HOMA-IR after a 
period of weight loss. However, effective long-term weight loss maintenance interventions 
among this high-risk group are few.   
While fasting measures have been useful for assessing health risks in the general 
population, postprandial measures are more sensitive to detecting true metabolic dysfunction and 
whole body insulin sensitivity.  No published research has assessed the change in postprandial 
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measures of insulin, glucose or insulin sensitivity throughout a weight loss and weight 
maintenance intervention among breast cancer survivors. Furthermore, breast cancer survivors 
spend over 65% of waking time in sedentary behaviors and less than 1% of their waking time in 
MVPA (100).  Changing sedentary time of breast cancer survivors may help to reduce the burden 
of co-morbidities and improve weight loss maintenance; however, there have been no 
interventions to date that have attempted to intervene in this manner.  
 
PURPOSE OF DISSERTATION 
 The goals of this project were to 1) assess the impact of a 10 month weight loss and 
weight loss maintenance intervention on components of metabolic syndrome (MetS) among 
obese and overweight breast cancer survivors, 2) determine relationships between changes in 
dietary and physical activity variables and changes in the components of MetS, 3) examine 
differences in fasting and postprandial glucose and insulin and measures of insulin sensitivity 
following the same weight management intervention among breast cancer survivors, 4) 
determine if change in weight, dietary intake or physical activity were predictors of 
improvements in insulin sensitivity after a weight management intervention, 5) identify barriers 
to reduce sedentary behavior within a weight maintenance intervention among breast cancer 
survivors.  
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CHAPTER TWO 
 
IMPROVEMENTS IN METABOLIC SYNDROME AFTER A WEIGHT 
MANAGEMENT INTERVENTION AMONG BREAST CANCER SURVIVORS 
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Abstract: 
Introduction:  Metabolic syndrome is a clustering of risk factors that have important prognostic 
and co-morbid implications for breast cancer survivors.  Achieving and maintaining a healthy 
weight can alleviate the components of MetS in the general population; however less is known 
about the impact of weight loss and weight loss maintenance on MetS components among breast 
cancer survivors. The objective of this study was to assess the impact of weight loss and weight 
loss maintenance on components of MetS among obese and overweight breast cancer survivors 
and to determine relationships between changes in dietary and physical activity variables and 
changes in the components of MetS. Methods: Breast cancer survivors (n=24; age: 53±8.3 years, 
BMI; 33.3±3.6 kg/m2) were enrolled in a 10 month weight management intervention consisting 
of a 4 month weight loss phase with the goal of losing 10% of their baseline weight, followed by 
a 6 month weight loss maintenance phase.  Anthropometric variables, self-reported physical 
activity, 24 hour dietary recalls and MetS components were measured at baseline, 4 months and 
10 months. Results: A total of 22 women completed the study.  From baseline to four months, 
participants lost 10.7% ± 3.9% of their baseline weight and significantly reduced their waist 
circumference (-7.03 cm), fasting glucose (-7.14 mg/dl), triglycerides (-22.23 mg/dl), and HDL-
C (-5.59 mg/dl).  Percent weight loss from baseline to 4 months was significantly associated with 
reductions in waist circumference(r=0.67), decreases in percent calories from fat(r=0.52), and 
increases in fruit and vegetable intake(r=-0.54). Increases in self-reported physical activity was 
associated with decreases in fasting glucose, (r=-0.458), but not other MetS components. From 4 
to 10 months, weight did not change significantly, but there were additional significant 
reductions in waist circumference (-2.76 cm) and increases in HDL-C (+11.82 mg/dl).  Percent 
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weight change from 4 to 10 months was significantly associated with further decreases in waist 
circumference (r=0.88) and increases in HDL-C(r=-0.49). Conclusions: Components of MetS 
were successfully ameliorated after a 4 month weight loss phase and sustained after a 6 month 
weight loss maintenance phase among breast cancer survivors.   
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Introduction: 
For the 3.1 million breast cancer survivors currently living in the United States, obesity is 
a mounting threat to their cancer prognosis, overall health and longevity (124, 125).  Thus, 
achieving and maintaining a healthy weight is crucial for this high-risk population. Metabolic 
syndrome (MetS) is a grouping of risk factors associated with obesity and insulin resistance that 
has prognostic value for recurrence and death among breast cancer survivors (13, 62).  The 
components of MetS - abdominal obesity, hyperglycemia, hypertension, and dyslipidemia – are 
independently associated with increased risk of breast cancer recurrence; however, the greatest 
risk is evident when viewed collectively (17).  Furthermore, MetS is a well-known risk factor for 
cardiovascular disease, the most common cause of death among older, early-stage breast cancer 
survivors (15, 21, 126).   
Effective lifestyle strategies have successfully improved the components of MetS among 
the general population (127, 128).  Adherence to the Mediterranean diet, the Dietary Approach to 
Stop Hypertension, and low glycemic index diets, have all shown beneficial changes in MetS 
components with and without calorie restriction (129-133). An increase in aerobic activity 
without changing diet also results in improvements in all MetS components (134). However, the 
majority of the lifestyle modification studies reporting improvements in MetS components have 
also reported clinically meaningful weight loss (-5-10% of baseline weight) (135). Consequently, 
interventions targeting both diet and physical activity have resulted in enhanced improvement in 
the components of MetS and the overall prevalence of MetS among the general population (131, 
132).   A large meta-analysis assessing the effect of lifestyle interventions targeting weight loss 
through diet and exercise on MetS reported the proportion of resolution of MetS was 1.5 to 2.7 
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times greater in the lifestyle intervention groups compared to the control groups (education only) 
(128).   
However, few studies have analyzed the effect of weight loss and weight loss 
maintenance on MetS and its components among breast cancer survivors. One trial examined the 
effects of a 16-week exercise intervention among breast cancer survivors and reported 
subsequent significant increases in MetS in participants who adhered to the prescribed exercise 
(136).  Dietary interventions in the context of MetS have shown that adherence to low 
carbohydrate and low fat diets both equally improve MetS among breast cancer survivors (27).  
To our knowledge, these are the only published studies that have assessed the impact of diet and 
exercise on MetS among breast cancer survivors; however, none have assessed MetS in the 
context of weight loss and weight loss maintenance.   
Effective and sustainable lifestyle interventions to alleviate MetS among breast cancer 
survivors have not been identified. The purpose of this analysis was to examine the effects of 
weight loss and weight loss maintenance on MetS and its components among overweight and 
obese breast cancer survivors.  
 
Methods: 
Sample 
Obese and overweight breast cancer survivors (n=24) were identified through chart 
reviews from the University of Kansas Cancer Center Registry.  Those who were eligible based 
on chart review (n=113) were contacted to complete a series of screening questionnaires by 
phone (Figure 2.1).  
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Eligible participants were women < 75 years old with a BMI 27-45 kg/m2, who were 
diagnosed with Stage I-IIIc breast cancer within the past 10 years, completed all local and 
systemic therapy at least 3 months prior to screening, and received clearance from their 
oncologist or current medical provider to participate in a weight loss study. At baseline, women 
Chart reviews 
n=286 
Ineligible 
n=173 
Contacted to pre-
screen 
n=113 
Unable to 
reach 
n=57 
Ineligible 
n=16 
Completed full 
screen 
n=40 
Ineligible 
n=12 
Eligible based on 
full-screen 
n=28 
Declined 
participation 
n=4 Baseline testing 
n=24 
Dropped 
n=1 
4 Month testing 
Completed Phase I: Weight loss  
n=23 
Lost to     
follow-up 
n=1 
10 Month testing 
Completed Phase 2: Weight loss maintenance 
n=22 
Figure 2.1. Recruitment and Intervention Consort Diagram   
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had to be currently inactive (< 90 min/week of moderate to vigorous physical activity (MVPA), 
able to walk briskly, and have access to a phone and computer.  Women were excluded if they 
were current smokers, had prior diagnosis of diabetes or were taking insulin, metformin or 
sulfonylureas, had another cancer diagnosis in the past 5 years other than non-melanoma skin 
cancer, had pending joint replacements, a history of bariatric surgery, and those who had 
participated in a formal weight loss program or used pharmacotherapy for weight loss within 6 
months prior to enrollment.  Women who screened positive for binge eating disorder, current 
major depressive disorder or current substance abuse were also excluded. The procedures for this 
study were approved by the Human Subjects Committee at the University of Kansas Medical 
Center under protocol #13700 and comply with the Declaration of Helenski.  
 
Intervention  
Phase One: Weight loss 
During phase one  (baseline to 4 months), participants were encouraged to lose 10% of 
their baseline weight through a combination of decreased caloric intake and increased MVPA. 
Group meetings were held on a weekly basis via conference call with one in-person meeting per 
month.  The intervention sessions were based on social cognitive theory and led by a trained 
group facilitator.  Weekly sessions included topics on nutrition, physical activity, self-
monitoring, and breast cancer survivorship (Appendix II).   
During weight loss, participants were instructed to follow a diet containing 1200-1500 
calories per day and less than 25% of calories from fat and include at least 5 one-cup servings of 
fruits and vegetables, two pre-prepared frozen meals and two whey-based protein meal 
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replacement shakes per day. Participants were asked to purchase pre-prepared frozen meals that 
contained less than 350 calories and less than 9 grams of fat. In addition, participants were 
provided with whey-based protein meal replacement shakes (120 kcal and 21grams protein per 
shake) to ensure they were meeting their protein needs and to aid in satiety.  Participants were 
also encouraged to increase MVPA throughout the program to achieve a goal of 225 minutes per 
week, most commonly through brisk walking.  
Phase 2: Weight loss maintenance intervention  
During Phase 2, participants were encouraged to maintain their weight loss and were 
given a new individualized calorie goal calculated from the Harris-Benedict equation (137). 
During the maintenance phase, group meetings were held bi-weekly and were focused on relapse 
prevention using the problem-solving model developed by Perri et al (138).  Participants were 
encouraged to continue to consume at least one pre-prepared frozen meal and one whey based 
protein shake per day while incorporating one healthy home-prepared meal.  They were 
instructed to maintain 225 minutes of MVPA per week.   
Measures 
Demographic and breast cancer history information were collected at baseline.  Weight, 
waist circumference, blood pressure, triglycerides, HDL-C, and fasting glucose were examined 
at baseline, 4 month, and 10 month. Diet and physical activity measures were also measured at 
each time point.    
Anthropometrics   
Participants were weighed on a calibrated digital scale (± 0.1 lb; Befour, Inc) in light 
clothing without shoes. Weight measurements were taken in duplicate.  Height was measured 
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using a portable stadiometer (± 0.1 cm; SECA217) without shoes. Height measurements were 
taken in duplicate and a third measure was taken if the first two measures differed by 2.0 cm or 
more.  Waist circumference was taken at the narrowest point waist upon participant full 
exhalation and measured to the nearest 0.1 cm using a tension-loaded tape measure. Waist 
circumference measures were taken in duplicate and a third measure was taken if the first two 
differed by 2.0 cm or more.  All duplicate and/or triplicate measures were averaged and 
recorded.  
Blood Pressure  
A clinical research nurse measured systolic and diastolic blood pressure with an 
automated oscillometric device after the participant had rested in a seated position for 5 minutes.  
Two measurements were taken and recorded. If either the systolic or diastolic measurements 
were greater than 5mm Hg apart, a third measurement was taken after a one-minute break. All 
duplicate and/or triplicate measures were averaged and recorded. 
Blood Collection and Assays 
 A clinical research nurse placed a small in-line catheter in the antecubital vein and 
collected fasting blood samples (10 ml) after an overnight fast of 10-12 hours. Participants were 
asked to refrain from physical activity for 24 hours prior to their blood draw and were instructed 
to consume a standardized meal consisting of a specific frozen entrée and apple 12 hours before 
their appointment in order to control for variability due to the macronutrient distribution of meal 
choices.  The blood samples were processed within 30 minutes of collection and centrifuged for 
10 minutes at 3500 RPM.  Serum was aliquoted into cryo-vials and stored in a -80°C freezer 
until the end of the 10 month study.  Triglycerides, HDL-C and glucose were enzymatically 
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measured using an ADVIA® 1800 Chemistry systems (Siemens Healthcare Diagnostics Inc; 
Tarrytown, NY). All samples were analyzed at Physicians Reference Laboratory in Overland 
Park, Kansas.  Samples from all time points were run together to avoid batch variation. 
Assessment of MetS 
 For this study, the definition of MetS in women was based on a joint interim statement of 
the International Diabetes Federation Task Force on Epidemiology and Prevention; National 
Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; 
International Atherosclerosis Society; and International Association for the Study of Obesity, 
which states the combination of any three or more of the following criteria indicates diagnosis of 
MetS: elevated fasting glucose (≥ 100 mg/dl) or pharmacologic treatment; central adiposity (≥ 
88cm waist circumference); elevated serum triglycerides (≥ 150 mg/dl) or pharmacologic 
treatment for elevated triglycerides; low HDL-C cholesterol (<50 mg/dl) or pharmacologic 
treatment for elevated HDL-C); and elevated blood pressure (systolic ≥ 130 mm Hg and/or 
diastolic ≥ 85 mm Hg ) or antihypertensive drug treatment(16).  
Diet  
Dietary intake was assessed by 24-hour diet recalls on 2 non-consecutive days by trained 
staff.  The recalls were taken on one weekday and one weekend day using the USDA multiple-
pass approach. The first recall was completed at the in-person baseline orientation visit with 2 
and 3 dimensional food models to help participants estimate accurate portion sizes.  The second 
recall was completed over the phone using a food amounts booklet containing food photos and 2 
dimensional food models to estimate accurate portion sizes.  During the 4 and 10 month 
assessment visits, both 24-hour dietary recalls were conducted over the phone.  The 24-hour 
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dietary recalls were entered into the Nutrition Data System for Research (NDSR, 2012) software 
and assessed for energy, macronutrients and food group servings.  
Physical Activity  
Participants completed the Modifiable Activity Questionnaire, a self-report measure that 
assesses leisure activities, including both sports and recreational activities over a one-week time 
frame. Activity levels were scored based on the product of the duration and frequency of the 
activity and were weighted based on Metabolic Equivalents (MET) values for that particular 
activity. Data from all activities were summed and presented as MET hours per week (139).    
 
Statistical Analysis  
Descriptive data are presented as mean ± standard deviation or frequency %(n) for all 
participants.  A repeated measures ANOVA was conducted among participants who completed 
through 10 month testing to determine the effect of the intervention on MetS components at three 
time points (baseline, 4 months, 10 months).  Post hoc analyses were conducted using the 
Bonferroni adjustment and pairwise comparisons were examined.  A McNemar chi-square test 
was used to determine the association between time point and presence of MetS among the 
sample.  Pearson’s product moment correlations were conducted to determine correlations 
between baseline to 4  month changes and 4 month to 10 month changes in weight loss, dietary 
factors, physical activity and MetS components.  For variables that violated the Shapiro-Wilk 
test for normality, Spearman’s rho was conducted. All analyses were completed using IBM SPSS 
Statistics, Version 22.0; IBM Corporation, Armonk, NY and statistical significance was defined 
as p<0.05.   
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Results 
Baseline Characteristic: 
There were 24 participants enrolled in the study and 22 participants who completed all 
three assessment visits.  
Table 2.1. Participant Baseline Characteristics (n=24) 
 Mean ± SD or n (%) Range 
Age (years) 53.0 ± 8.3 39.7-65.2 
BMI (kg/m2) 33.3 ± 3.6 27.4-41.2 
Weight (kg) 88.9 ± 10.7 70.0 – 108.3 
Time since diagnosis (years) 3.9 ± 1.9 1.2-7.3 
Cancer stage (AJCC 7th Edition) 
Stage I 
Stage II 
Stage III 
 
14 (58.3%) 
10 (41.7%) 
0   (0%) 
Current Antihormone Therapy Use 17 (70.8%) 
Estrogen Receptor Status 
Positive 
Negative 
 
17 (70.8%) 
7 (29.2%) 
Treatment and Surgical history  
Chemotherapy 
Radiation 
Mastectomy 
Lumpectomy 
 
15 (62.5%) 
14 (58.3%) 
11 (45.8%) 
13 (54.2%) 
Race 
African American 
Native Hawaiian or other Pacific Islander  
White  
 
1 (4.2%) 
1 (4.2%) 
22 (91.7%) 
Education Status  
Less than high school  
High school/GED  
Some college or associate’s degree 
Bachelor’s degree 
Graduate level degree  
 
1 (4.2%) 
3 (12.5%)  
9 (37.5%) 
6 (25.5%) 
5 (20.8%)  
  
Employment Status  
Full Time 
Part Time 
Unemployed/Retired 
 
13 (54.2%) 
7 (29.2%) 
4 (16.7%) 
Marital Status  
Married/Cohabitating  
Divorced/Separated  
Single/Widowed  
 
18 (75%) 
3 (12.5%) 
3 (12.5%) 
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One participant dropped out of the study for personal reasons between baseline and 4 
month testing and one participant was lost to follow up between 4 and 10 months (Figure 2.1). 
Participant baseline characteristics are described in Table 2.1.  On average, women were middle-
aged, obese, white, and well-educated.  At the time enrollment, participants were an average of 
3.9 ± 1.9 years out from their breast cancer diagnosis. 
Weight Loss Results 
 After the four-month weight loss phase, participants lost an average of 10.7 ± 3.9% of 
their baseline weight. Participants significantly reduced total daily caloric intake and percent 
calories from fat, and increased daily totals of fruit and vegetable servings (all p<0.01) after the 
four month weight loss phase (Table 2.2).  Self-reported MVPA increased by 58.57  ± 131.67 
minutes per week from baseline to four months. Participants did not increase their physical 
activity to the recommended 225 minutes per week throughout the intervention; reporting 125.70 
± 110.07 minutes per week at 4 months.  
Table 2.2 Changes in Weight, Diet and MVPA  
 Baseline 
n=22 
Mean ± SD 
4 months 
n=22 
Mean ± SD 
10 months 
n=221 
Mean ± SD 
Weight (kg) 89.5  ± 10.5 79.8 ± 10.1a 79.0 ± 11.5 a 
Calories (kcals per day) 1776.3 ± 435.4 1343.4 ± 249.2 a 1367.8 ± 383.6 a 
Percent calories from fat (% kcal) 35.9% ± 7.7% 22.1% ± 8.3%a 29.6% ± 7.2% a ,b 
Percent calories from MUFA (% kcal) 12.4% ± 3.1% 7.3% ± 3.0%a 10.1% ± 3.0% a ,b 
Percent calories from PUFA (% kcal) 8.8% ± 3.2% 5.5% ± 2.9%a 6.6% ± 2.7% a 
Percent calories from saturated fat (% kcal) 11.9% ± 2.8% 7.2% ± 3.0%a 10.1% ± 3.1% a 
Percent calories from carbohydrates (% kcal) 44.4% ± 7.9% 53.4% ± 7.8%a 49.0% ± 8.2% a 
Percent calories from protein (% kcal) 17.1% ± 4.1% 23.5% ± 4.9%a 20.8% ± 5.3% a 
Fruit and vegetable intake (servings per day) 4.4 ± 2.6 7.8 ± 3.0a 5.7 ± 3.0 a 
MVPA (min/wk) 60.6 ± 96.9 131.4 ± 109.1a 95.7 ± 100.0 a 
MVPA (METS/wk) 4.2 ± 6.6 8.7 ± 7.9a 7.1 ± 8.3a 
Data presented as mean  ±  SD. 1four people could not be reached for 24 hour diet recalls at 10 months; n=18 for dietary 
data at 10 months; aindicates value is significantly different from baseline (p≤0.01); bindicates value is significantly 
different from 4 months (p≤0.01). 
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The number of participants who met criteria for MetS decreased from 12 participants 
(54.5%) at baseline to 9 participants (40.9%) at 4 months; however, the relationship between 
time point and the presence of MetS was not significant (Figure 2.2). 
 
 
 
 
 
 
 
 
 
 
 
 
Mean values for waist circumference and fasting triglycerides were in high-risk ranges at 
baseline; whereas; mean blood pressure, triglycerides, and HDL-C did not meet their respective 
component criteria for MetS at baseline (Figure 2.3). Participants significantly reduced their 
waist circumference (-7.03 cm; p≤0.01), fasting glucose (-7.14 mg/dl; p≤0.01), and triglycerides 
(-22.23 mg/dl; p≤0.05), from baseline to four months. The weight loss phase resulted in a 
statistically significant unfavorable change in HDL-C (-5.59 mg/dl; p≤0.05).  
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Figure 2.3 Change in MetS Components over Time (n=22) 
  
 Figure 2.3 The effect of each time point (baseline, 4 months and 10 months) on components of 
MetS. Data are presented as mean ± SE.  *values significant at p≤0.05 for change from previous 
time point. **values significant at p≤0.01 for change from previous time point.                  indicates 
cutoff for MetS                             indicates difference between baseline and 10 months.  
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Scatterplots were examined to determine the relationships between percent weight loss 
from baseline to 4 months and changes in dietary factors, physical activity, and the components 
of MetS. There were statistically significant relationships between percent weight loss from 
baseline to 4 months and change in waist circumference (r=0.67, p≤0.01), change in percent 
calories from fat (r=0.52, p≤0.01), and change in fruit and vegetable intake (r=-0.54, p≤0.01).  
In other words, participants with greater percent weight loss had greater decreases in waist 
circumference, greater decreases in percent calories from fat, and greater increases in fruit and 
vegetable intake.   Additionally, there was a negative association between changes in percent 
calories from fat and change in total fruit and vegetable intake, such that as participants 
decreased their percent calories from fat, they increased their fruit and vegetable intake (r=-
0.511, p≤0.05).   Decreases in percent of calories from fat were also related to favorable changes 
in serum triglycerides (r=0.454, p≤0.05). Additionally, participants who had favorable changes 
in triglycerides had unfavorable changes in HDL-C from baseline to 4 months (r=0.433, 
p≤0.05).  Increases in self-reported MVPA from baseline to 4 months were associated with 
decreases in fasting glucose (r=-0.458; p≤0.05).  
 
Weight Maintenance Results  
There was no significant change in body weight during the weight maintenance phase     
(-0.76 kg ± 3.59 kg). Four participants could not be reached for diet recalls after 10 month 
testing, thus the dietary data reflects a sample of n=18.  From 4 to 10 months, participants did not 
significantly change their total daily calorie intake or fruit and vegetable intake (Table 2.2).  
However, participants reported a significant increase in percent calories from fat from 4 to 10 
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months (+7.92% ± 10.14%, p≤0.01). Self-reported MVPA was 95.68 ± 99.99 minutes per week 
at 10 months, a non-significant change from 4 months (Table 2.2).   
The number of people who met criteria for metabolic syndrome decreased from 9 
participants (40.9%) at 4 months to 6 participants (27.3%) at 10 months (Figure 2.2).  However, 
this change was not significant. Participants significantly improved their HDL-C levels by 11.82 
mg/dl from 4 to 10 months (p≤0.001)(Figure 2.3). Participants also continued to reduce their 
waist circumference from 4-10 months (-2.76 cm; p≤0.01). Blood pressure, triglycerides, and 
fasting glucose did not change significantly from 4 months to 10 months.   
The relationship between significant changes in lifestyle factors and metabolic syndrome 
components from 4 to 10 months was also examined.   Percent weight loss from 4 to 10 months 
was associated with greater changes in waist circumference(r=0.883, p≤0.001), greater increases 
in percent calories from fat (r=0.572, p≤0.05) and greater increases in HDL-C (r=-0.492; 
p≤0.05).  Favorable changes in waist circumference from 4 to 10 months were associated with 
greater increases in percent calories from fat (r=0.572, p≤0.05).  As total daily calorie intake 
decreased from 4 to 10 months, triglycerides also decreased (r=0.533; p≤0.05). 
 
Discussion 
Our findings demonstrate several components of MetS can be effectively improved after 
a weight loss intervention and sustained after a weight loss maintenance intervention among 
breast cancer survivors. More than half of the women who completed the study presented with 
MetS at baseline thereby placing them at greater risk for breast cancer recurrence and other 
related co-morbidities. The prevalence of MetS in our sample is comparable to what others have 
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observed in larger samples of breast cancer survivors (136, 140).  Although, the number of 
participants who met criteria for MetS did not significantly change throughout our study, our 10 
month lifestyle intervention had a positive impact on waist circumference, fasting glucose, 
triglycerides and HDL-C.   
Weight loss consistently results in subsequent improvements in MetS among the general 
population (15, 128, 141). In our sample, weight loss produced significant improvements in 
waist circumference, fasting glucose and triglycerides; whereas, HDL-C- decreased significantly 
throughout the 4 month weight loss intervention.  The participants in our sample reported a mean 
decrease in calories from fat (-13.8% ± 11.57%) and increases in percent calories from 
carbohydrate and protein (+8.92% ± 12.13%, +6.4% ± 6.80%, respectively) from baseline to four 
months, suggesting many participants exchanged fat for carbohydrates and protein during the 
weight loss phase. Furthermore, the type of fat consumed is known to play an important role in 
the effects on the components of MetS (142).  In our sample, the percent of calories consumed 
from saturated fatty acids, monounsaturated fatty acids (MUFAS) and polyunsaturated fatty 
acids (PUFAS) significantly decreased by -4.7% ± 4.25%, -5.12 ± 4.40%, and -3.31 ± 4.39% 
respectively (all p≤0.05).  While the overall decrease in saturated fat intake likely helped to 
resolve MetS, the simultaneous decrease in MUFAs and PUFAs may have contributed to the 
overall decrease in HDL-C during the weight loss phase. Furthermore, we observed no changes 
in blood pressure in our sample.  This finding is not in line with previous studies reporting 
significant weight loss after a lifestyle intervention (128). However, the mean systolic and 
diastolic blood pressure of the participants in our sample were in the normal range at the start of 
the study, thus improvements in blood pressure were not required for improvements in MetS.  
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 Weight management interventions are shifting to focus on sustained weight maintenance 
because weight regain after weight loss is an unresolved obstacle (45). A recent meta-analysis 
examined the effect of maintenance of weight loss on MetS and concluded that 2-6% weight 
regain after weight loss is associated with a return to baseline MetS status (127).  Furthermore, 
the same meta-analysis reported weight loss and weight maintenance to have minimal overall 
impact on HDL-C. However, in our sample, HDL-C increased above baseline levels after the 10 
month intervention.  Maintaining adequate HDL-C is important for prevention of cardiovascular 
disease and death – especially among breast cancer survivors. Although there were initial 
detrimental changes in HDL-C cholesterol after weight loss, the weight maintenance phase 
showed full recovery in HDL-C levels.  One study among healthy obese subjects also reported an 
increase in HDL-C after a period of weight loss maintenance (143).  The authors also reported an 
increase in MVPA during this phase, which could be a possible explanation for the increase in 
HDL-C during a period of no weight loss.  Furthermore, moderate levels of exercise during 
weight maintenance have been shown to sustain improvements in MetS after weight loss, even 
when up to 50% of weight loss is regained (144). This cannot explain the decrease in HDL-C in 
our sample, as the women did not report increases in MVPA during the maintenance phase.  
However, in our sample, it is possible the increase in dietary fat intake, specifically MUFAs and 
PUFAs, during the weight loss maintenance phase may have played a role in the increase in 
HDL-C (22).  
Waist circumference continued to decrease during the weight maintenance phase 
although there was not a significant change in weight.  The change in waist circumference 
without weight loss has been noted in other studies, particularly when there are decreases in 
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visceral fat (136, 145).  We did not measure visceral fat mass, so it is difficult to know if this 
effect is true in our sample.  
The relationships between MetS components and changes in dietary and physical activity 
variables from baseline to 4 months confirmed what has been observed in the literature in the 
general population.  While reductions in percent calories from fat was associated with favorable 
changes in percent weight loss, the opposite was true from 4 months to 10 months.  During the 
weight maintenance phase, participants who continued to lose weight had greater increases in 
percent calories from fat. Total caloric intake did not change significantly during the weight loss 
maintenance phase.  However, participants who continued to lose weight during the weight loss 
maintenance phase continued to reduce calories, This is in line with the literature showing 
caloric restriction is more important than macronutrient distribution for weight management 
(146).  It should be noted that 4 participants could not be reached for dietary recalls at 10 
months, thus this relationship is only true of a smaller portion of the sample (n=18).  
Given the relationship between breast cancer, heart disease, and MetS, the identification 
of effective lifestyle strategies to alleviate the burden of MetS is of great value to breast cancer 
survivors.   A large, randomized controlled trial is currently underway to determine the impact of 
a 6-month aerobic and resistance exercise intervention on MetS components among breast cancer 
survivors, and will likely contribute to gaps in the literature regarding the mechanism behind 
MetS and exercise among this high-risk group (147).  A recent review by Azard et al. highlighted 
the importance of establishing effective lifestyle interventions to address MetS among breast 
cancer survivors (148).  The present study is one such example of how a lifestyle intervention 
can successfully reduce the components of MetS among breast cancer survivors.    
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A major strength of this study was the presence of distinct weight loss and weight loss 
mainenance phases and the ability to assess MetS in a high-risk group of breast cancer survivors.  
Additionally, we followed our participants through a weight loss phase and weight maintenance 
phase, and were thus able to demonstrate the effects of each on MetS.  A limitation of this study 
was the small sample size and the lack of a control group in which to compare the intervention 
results.  Furthermore, participants did not achieve the recommended physical activity 
requirements throughout the intervention, making it difficult to interpret the results in the context 
of exercise.  We could not reach four participants at the 10 month time point to collect diet 
recalls, which limits the interpretability of the dietary changes during the maintenance phase.  
In conclusion, components of metabolic syndrome can be successfully ameliorated 
through weight management lifestyle intervention among breast cancer survivors.  Large-scale, 
randomized controlled trials should be conducted to determine an optimal prescription of weight 
management, dietary changes and exercise to resolve MetS in the growing population of breast 
cancer survivors.  
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CHAPTER THREE 
 
IMPACT OF A WEIGHT MANAGAMENT INTERVENTION ON FASTING AND 
POSTPRANDIAL MEASURES OF INSULIN AND INSULIN RESISTANCE AMONG 
BREAST CANCER SURVIVORS 
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Abstract:  
Introduction: Fasting insulin has been associated with breast cancer outcomes; however, 
postprandial measures may be a more sensitive to impaired insulin resistance with possibly 
greater prognostic value.  Weight management through diet and physical activity are known to 
play an important role in improving insulin sensitivity, but less is known about these effects 
among breast cancer survivors. The purpose of this analysis was to assess the impact of weight 
management intervention on fasting insulin, postprandial insulin and glucose and measures of 
insulin resistance. Methods:  Breast cancer survivors (n=22) completed a 4 month weight loss 
intervention and were randomized to a standard weight maintenance intervention (MAINT) or a 
maintenance intervention with an added component of reducing sedentary behavior (MAINT + 
SED).  At baseline, 4 months and 10 months fasting blood samples were collected and a 
standardized meal was provided to each participant.  Blood was collected 30 min, 45 min, 60 
min, 90 min and 120 min post meal. Changes in fasting insulin and glucose, postprandial insulin 
and glucose, and two measures of insulin resistance (HOMA-IR and Matsuda Index) were 
recorded at 4 months and 10 months. Results: There was no difference between groups in weight 
loss or any of the measured glycemic parameters. Fasting glucose (-7.63 mg/dl) and insulin 
levels (-5.66 mU/l) were significantly reduced in both groups after weight loss and were 
maintained after weight loss maintenance. Postprandial insulin (AUC and iAUC) significantly 
decreased from baseline to 4 months and reductions were maintained at 10 months; however 
there was no change in postprandial glucose (AUC and iAUC) at either time point.  HOMA-IR 
decreased by 49% and Matsuda Index scores increased by 67% from baseline to 10 months.  
Change in fasting insulin was not associated with change in 10 month percent weight loss, 
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however changes in Matsuda index score from baseline to 10 months showed a modest by 
significant association with percent weight loss from baseline to 10 months (r=-0.545).  
Conclusions: Insulin sensitivity was significantly improved after a period of weight loss and 
weight loss maintenance among breast cancer survivors.  Measures of insulin resistance, which 
incorporate postprandial measures, may be more strongly correlated with reductions in weight 
when compared to fasting measures.  
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Introduction  
Insulin is an anabolic peptide hormone responsible for exhibiting tight control over 
hepatic glucose production and peripheral glucose utilization (82). Chronically high levels of 
insulin are pervasive in obesity and result in diminished whole body insulin sensitivity (52). 
Obesity induced hyperinsulinemia is associated with a two fold increased risk of recurrence and 
a four-fold increased risk of death among breast cancer survivors (60-62, 149). Furthermore, 
insulin is well known for its mitogenic properties, which are implicated in breast cancer 
recurrence and death (54).   In addition to breast cancer recurrence and death, insulin resistance 
is a serious risk factor for heart disease, type 2 diabetes and all cause mortality – all of which are 
co-morbidities among cancer survivors (38, 126).  
While fasting insulin levels have been highly correlated with outcomes among breast 
cancer survivors (61), postprandial measures of insulin sensitivity may be more indicative of 
metabolic dysfunction among this high risk group. The gold standard for assessment of whole-
body insulin sensitivity is measured through the hyperinsulinemic-euglycemic insulin clamp 
technique (73).   However, the most common assessment of insulin sensitivity and pancreatic 
beta cell function relies on more simple measures of fasting insulin and fasting glucose to 
calculate the homeostatic model of assessment (HOMA-IR) (75). HOMA-IR is highly correlated 
with the clamp method and is specifically useful in longitudinal observational studies because of 
its ease of use and routine measurement (75, 76). The Matsuda Index is a postprandial measure 
of insulin sensitivity that is based mathematical model designed to estimate whole body insulin 
sensitivity. The Matsuda Index shows a slightly stronger correlation (r=0.73) with the clamp 
method when compared to HOMA-IR (r=0.69) (77).  The difference between the strength of the 
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correlations these correlations are expected to be greater with varying levels of insulin 
sensitivity. The Matsuda Index was first developed as a method of measuring insulin sensitivity 
following the oral glucose tolerance test (OGTT), but it has been used to assess insulin 
sensitivity after a mixed meal (89).  
The HOMA-IR method has successfully identified insulin resistance in breast cancer 
survivors (150). The greatest reductions in HOMA-IR are evidenced in interventions targeting 
weight loss through both diet and physical activity when compared to targeting diet alone or 
activity alone (31).  However, no published research has examined the changes in postprandial 
insulin after a period of weight loss and weight loss maintenance among breast cancer survivors. 
Furthermore, changes in insulin sensitivity as measured by the Matsuda Index after a weight 
management intervention have not been assessed in breast cancer survivors. 
Sedentary behavior may play an important role in the development of insulin resistance 
(116, 151). Population based studies in the U.S. have shown significant associations between 
objectively measured sedentary time and both fasting insulin and insulin resistance (104, 117).  
Inactivity in the form of sedentary behavior is as an important risk factor for breast cancer 
survivors as well (100).  Few interventions have aimed to reduce sedentary time and no 
published studies have reduced sedentary time within a weight management intervention (109). 
The degree to which MVPA and sedentary activity are predictive of change in insulin response 
within a weight loss intervention in the general population is more controversial with some 
interventions revealing a protective effect of MVPA and insulin resistance (68, 69) and others 
showing no effect (69, 71). 
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The purpose of this analysis was to examine changes in fasting insulin and insulin 
sensitivity throughout a weight management intervention among breast cancer survivors.  An 
additional aim of this study was to examine the relationship between changes in weight, total 
calorie intake, sedentary behavior and MVPA and changes in fasting insulin and insulin 
sensitivity throughout this weight management intervention.  
 
Methods  
Overview  
This was a10-month randomized controlled trial examining a novel approach to weight 
loss maintenance through decreasing sedentary behavior among 24 overweight and obese breast 
cancer survivors.  This pilot study consisted of two main phases:  Phase 1 – Weight Loss (0-4 
months); Phase 2 – Weight Loss Maintenance (4-10 months)(Figure 3.1). During Phase 1, all 
participants were encouraged to lose 10% of their baseline weight through a reduced calorie diet 
and the incorporation of moderate to vigorous physical activity (MVPA). During Phase 2, 
participants were randomized to either receive our standard maintenance intervention for 6 
months (MAINT) (37) or to receive our standard maintenance intervention plus an additional 
component aimed to decrease sedentary behavior for 6 months (MAINT + SED).  Data 
collection visits took place at baseline, 4 months and 10 months.   
 
Sample  
 Recruitment and eligibility details can be found in Chapter 2. Briefly, 24 overweight and 
obese breast cancer survivors were recruited from the University of Kansas Cancer Center 
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Registry and all participants had physician clearance to participate. The procedures for this study 
were approved by the Human Subjects Committee at the University of Kansas Medical Center 
under protocol #13700 and comply with the Declaration of Helenski.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phase One: Weight Loss 
 
Phase Two: Maintenance 
 
Baseline Testing  
n=24 
Randomization 
MAINT 
n=12 
MAINT + SED 
n=12 
4 Month Testing 
n=23 
Randomization revealed 
10 Month Testing  
n=22 
Lost to follow up 
n=1 
Dropped  
n=1 
Figure 3.1 Intervention Consort Diagram 
MAINT 
n=12 
MAINT + SED 
n=11 
0-4 months 
 
4-10 months 
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Intervention  
Phase One: Weight Loss 
All participants were encouraged to lose 10% of their baseline weight.  They were 
instructed to consume at least five one-cup servings of fruits and vegetables, two frozen pre-
prepared meals and two whey protein shakes per day.  Participants were also asked to work up to 
225 minutes of MVPA per week, most commonly through brisk walking. For the first four 
months, participants met weekly via conference call and were led by an experienced group 
facilitator.  Once each month, participants were given the option to come to an in-person 
meeting.  If participants could not attend the in-person meeting, they were still asked to attend 
the meeting via conference call.  The in-person meetings included a weigh-in component and 
allowed the participants to meet face-to-face with each other and their group leader.  Group 
sessions focused on nutrition, physical activity, self-monitoring and breast cancer survivorship 
(Appendix II).  
Phase Two: Weight Loss Maintenance  
 After the four-month weight loss phase, participants completed either our standard 6 
month maintenance intervention (MAINT) or our standard maintenance intervention with an 
added component to reduce sedentary behavior (MAINT + SED). Participants in both groups 
were given a maintenance calorie goal calculated by the Harris Benedict equation(137).   They 
were encouraged to consume at least five one-cup servings of fruits and vegetables, one pre-
prepared meal and one whey protein shake per day; however, they were also encouraged to 
consume one healthy home-prepared meal. Participants remained in the same groups from the 
weight loss phase to the weight maintenance phase.  Group meetings were held via conference 
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call every other week for six months.  During the maintenance phase, the meetings were less 
didactic and were based on the problem-solving model developed by Perri et al (43).    
 Participants in the MAINT + SED group also received a Fitbit Zip® activity tracker, a 
Fitbit Aria Smart Scale® and a Lose It® account to track their calories.  In addition to the 
standard maintenance components, participants were encouraged to reduce their overall sitting 
time by 1) increasing their light activity by an average of 30 minutes per day, 2) reducing their 
TV time to less than 90 minutes per day, and 3) reduce their bouts of uninterrupted sitting to no 
more than 30 minutes in duration.  
 
Measures  
Anthropometrics  
Anthropometric measurements are detailed in Chapter 2.  Briefly, height, weight, and 
waist circumference were measured and recorded according to our standard protocol.  
Activity 
All participants completed the Multi-context Sitting Time Questionnaire (MSTQ) and the 
Modifiable Activity Questionnaire (MAQ) at all time points. The MSTQ is a brief self report 
measure that assesses usual sitting time across occupational, leisure time and transportation 
domains on both weekdays and weekend days (152).  The MAQ is a self-report measure that 
assesses leisure activities, including both sports and recreational activities during the past week 
(139).   
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Blood Collection  
Fasting and postprandial samples were collected by nurses at the University of Kansas 
Clinical Research Center.  Participants were instructed to fast overnight (10-12h) and refrain 
from MVPA for 24 hours prior to their testing session to minimize the effects of acute physical 
activity on insulin. Participants were also asked not to consume caffeine or alcohol for 24 hours 
prior to their assessment.  All participants were instructed to eat the same frozen entrée and a 
similar apple exactly 12 hours before their testing session in order to control for variability due to 
macronutrient distribution of meal choices.  At baseline, entrées and apples were provided to 
participants at the orientation visit.  At 4 and 10 month testing, participants were asked to 
purchase the entrée and apple to consume 12 hours before their testing session.   
Upon completion of anthropomorphic measures, a small in-line catheter was placed in an 
arm vein, and a baseline blood sample (≤10 ml) was collected. Participants then consumed a 
standardized meal consisting of ~350 kcal and ~50 g carbohydrates (Table 3.1). Macronutrient 
distributions were chosen based on other studies using meals to assess postprandial glucose and 
insulin (153, 154). They were asked to consume the meal within a 10-15 minute period.  For the 
next 2 hours, they were asked to lie still in a reclining chair while nurses collect blood samples 
(≤ 10 ml) at 30, 45, 60, 90, and 120 minutes post-meal.  Serum was processed within 10 minutes 
of the draw time at 3500 PRM.  Serum was aliquoted into cryo-vials and stored in a -80°C 
freezer until the end of the 10 month study.   
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Table 3.1 Meal Composition  
 Amount Calories Fat (g) CHO (g) Pro (g) Fiber (g) 
Wheat bread 2 oz 151 2.1 27 6.2 2 
Butter 11 g 79 8.9 0 0.1 0 
Jam 11g 31 0 7.6 0 0.1 
SMART® Smoothie 10 g 34 0.3 1.3 6.7 0.3 
Grapes 75 g 52 0.1 13.6 0.5 0.7 
Total (grams)  347 11.4 49.5 13.5 3.1 
% of Total   29% 55% 16%  
 
All insulin samples were run together at a University of Kansas Medical Center 
laboratory (KIDDRC). Serum insulin was analyzed with a human ELISA kit (Genway #GWB-
9BC0DA, 40-521-475037).  Serum glucose was analyzed at Physicians Reference Laboratory in 
Overland Park, KS via the Glucose Oxidase Trinder method (ADVIA® Chemistry Systems. 
Siemens Healthcare Diagnostics Inc). 
Calculations 
Total area under the curve (AUC) and positive incremental area under the curve (iAUC) 
for insulin and glucose were calculated using the trapezoidal method (155).  Total AUC includes 
the entire area under the curve and positive iAUC subtracts baseline (fasting) measures from all 
subsequent reading and calculates the remaining area under the curve, eliminating all negative 
values that fall below baseline (fasting).  Positive iAUC is criticized for eliminating potential 
variance added by negative values(156). Total AUC is not dependent on changing baseline 
values and does not eliminate any values.  Both AUC and iAUC were calculated so as to gain 
perspective from both.  Surrogate measures of insulin resistance were calculated using HOMA-
IR and Matsuda Index.  HOMA-IR was calculated using the following equation, with higher 
HOMA-IR scores indicating more insulin resistance (75). 
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Matsuda Index scores were calculated according to the following equation (77), where mean 
postprandial (PP) glucose and insulin was calculated based on measures from 30 min, 45 min, 60 
min, 90 min and 120 min post meal. Higher Matsuda Index scores indicate more insulin 
sensitivity.  10000
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Statistical Analysis  
Participant baseline characteristics by group are described as mean ± standard deviation 
and range or frequency (Table 3.2).  A two-way repeated measures ANOVA was conducted to 
determine differences between groups at each time point for weight, activity levels, fasting 
insulin, fasting glucose, postprandial insulin (AUC and iAUC), postprandial glucose (AUC and 
iAUC), HOMA-IR, and Matsuda Index.  Post hoc analyses were conducted using the Bonferroni 
adjustment and pairwise comparisons were examined.  Linear regression was used to determine 
predictors of improvements in fasting insulin from baseline to 10 months.  Fasting insulin was 
chosen as an outcome variable because it is a simple and common measure implicated in 
prognosis and health of breast cancer survivors. The same predictors were used in a separate 
linear regression model to assess the improvements in insulin sensitivity as measured by the 
Matsuda index from baseline to 10 months.  Matsuda Index scores were chosen because of the 
postprandial nature of the measure of insulin sensitivity which could potentially be a useful 
prognostic indicator in this population. All analyses were completed using IBM SPSS Statistics, 
Version 22.0; IBM Corporation, Armonk, NY and statistical significance was defined as p≤0.05.   
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Results  
 Twenty-two participants completed the study: 12 in the MAINT arm and 10 in the 
MAINT + SED arm (Figure 3.1).  Participant baseline characteristics did not differ between 
groups (Table 3.2).  On average, women were obese and had high-risk waist circumference at 
enrollment. At the start of the study, all women were at least 1 year out for the time of their 
diagnosis of stage 1 or 2 breast cancer and 70.8% were taking antihormone therapy.  
Table 3.2 Participant Characteristics (n=22) 
 MAINT (n=12) MAINT + SED (n=10) 
 Mean ± SD or n (%) Range Mean ± SD or n (%) Range 
Age (years) 54.7 ± 6.9 43.8-64.0 51.1 ± 8.6 42.3-65.2 
BMI (kg/m2) 33.5 ± 3.7 27.4-38.7 33.3 ± 4.0 28.1-41.2 
Weight (kg) 88.3 ± 11.8 70.0-108.3 91.0 ± 9.2 76.3-104.0 
Waist circumf. (cm) 99.2 ± 8.0 89.6-112.8 97.8 ± 6.2 83.1-108.3 
Time since diagnosis 
(years) 4.1 ± 1.8 1.5-6.4 3.9 ± 2.2 1.2-7.3 
Cancer stage 
Stage I 
Stage II 
Stage III 
 
8 (66.7%) 
4 (33.3%) 
0 (0%) 
 
4 (40.0%) 
6 (60.0%) 
0 (0%) 
Current antihormone 
therapy use (% yes) 10 (83.3%) 5 (50%) 
 
Weight change did not differ between groups at any time point (Figure 3.2). The MAINT 
group reported a significantly greater change in MVPA from baseline to 4 months when 
compared to MAINT+SED (p≤0.05). Self-reported change in week day and weekend sitting time 
did not differ by group from baseline to 4 months. However, from 4 to 10 months, the MAINT + 
SED arm reported significantly less sitting time on weekends (-1.0 ± 2.4 hours per day) when 
compared to MAINT arm (0.7 ± 1.4 hours per day) (p≤0.05). 
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There was no difference between groups at any time point in fasting insulin, fasting 
glucose or insulin resistance measures.  The repeated measures ANOVA revealed favorable 
significant changes from baseline to 4 months in fasting insulin (-5.70 ± 1.31), fasting glucose   
(-7.74 ± 2.27), and HOMA-IR (-1.63 ± 0.39).   Matsuda index values significantly increased 
from baseline to four months (+2.03 ± 0.59) (Table 3.3).  
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Figure 3.2 Weight and Activity by Group At Baseline, 4 Months, and 10 Months  
Figure 3.2. The effect of groups (MAINT or MAINT + SED) on weight (A); MVPA 
(B); non-work day sitting time or weekend sitting time (C); and work day or weekday 
sitting time (D).  Data presented as mean. *indicates between group difference is 
significant (p≤0.05). 
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Table 3.3 Fasting Glucose, Insulin and Measures of Insulin Resistance 
Measure   Mean ± SE  
Fasting glucose (mg/dl) 
Baseline 
4 months 
10 months  
 
100.1 ± 2.52 
92.47 ± 1.40a 
91.90 ± 2.26a 
Fasting insulin (mU/L)  
Baseline  
4 months 
10 months 
 
13.61 ± 2.01 
7.95 ± 1.16a 
7.68 ± 1.29a 
HOMA-IR  
Baseline 
4 months 
10 months 
 
3.42 ± 0.53 
1.81 ± 0.27a 
1.75 ± 0.31a 
Matsuda Index  
Baseline 
4 months 
10 months 
 
4.57 ± 0.65 
6.60 ± 0.83a 
7.62 ± 0.94a 
Data are presented as mean ± SE. amean difference between baseline value significantly 
different (p≤0.01).  
 
Postprandial measures of insulin AUC and iAUC were significantly different from 
baseline to 4 months (Figure 3.3). Insulin levels were significantly different between baseline 
and 10 months for all draw times except 90 minutes. There was no difference in glucose AUC or 
iAUC from baseline to 4 months.  However, fasting glucose was significantly different from 
baseline to four months and from baseline to 10 months.  The 30 minute glucose levels were 
significantly different from baseline to 10 months, but not baseline to 4 months. There were no 
statistically significant changes between 4 months and 10 months for any of the examined 
variables.  
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Figure 3.3 The effect of three time points (baseline, 4 months, 10 months) on postprandial 
insulin levels (A); insulin AUC and positive iAUC (B); postprandial glucose levels (C); and 
glucose AUC and positive iAUC (D). Data for postprandial insulin and glucose represent mean 
± SE. aindicates baseline value is significantly different from 4 months (p≤0.01); b indicates 
baseline value is significantly different from 10 months (p≤0.01; *indicates value to 
significantly different from baseline (p<0.01). 
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The regression models revealed changes in diet and activity variables did not 
significantly predict changes in fasting insulin or changes in insulin sensitivity. Furthermore, the 
bivariate correlation between change in fasting insulin from baseline to 10 months and percent 
weight loss was also non-significant. However, there was a significant negative correlation 
between percent weight loss from baseline to 10 months and Matsuda Index score (r=-0.545; 
p<0.01) (Figure 3.4). 
 
 
 
 
 
 
Figure 3.4 Percent Weight Loss and Change in Insulin Sensitivity    
r = -0.545  
p ≤ 0.01 
Figure 3.4 The relationship between percent weight loss at 10 months and Matsuda Index 
change from baseline to 10 months. Data presented as one data point per participant and 
Pearson correlation coefficient (r), p value, and line of best fit 
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Discussion  
Our findings show fasting insulin and postprandial insulin levels were significantly 
improved after a weight loss intervention and were sustained during a 6 month period of weight 
maintenance.  Furthermore, insulin sensitivity improved among our sample of breast cancer 
survivors, evidenced by a 48% reduction in HOMA-IR scores and a 40% increase in Matsuda 
Index score from baseline to 10 months. This is in line with prior studies examining the effects of 
weight loss on fasting insulin in obese breast cancer survivors (27, 37, 67) and in obese women 
without breast cancer (72). In other weight management studies among overweight and obese 
breast cancer survivors, improvements in HOMA-IR scores have ranged from 17% - 30% (27, 
31). In our sample, the mean baseline HOMA-IR was indicative of insulin resistance as 
evidenced by a HOMA-IR value greater than 2.5, a commonly used cut point for determining 
insulin resistance (150).  However, after the 4 month weight loss phase and the 6 month 
maintenance phase, mean HOMA-IR values were decreased below the 2.5 cut point, suggesting 
the women in our sample significantly improved their insulin sensitivity after a period of weight 
loss and maintenance.       
 In the pre-diabetic state, an individual can have normal fasting glucose levels, but can 
present with impaired glucose tolerance following a meal (74). The oral glucose tolerance test 
(OGTT) has been used clinically to detect impaired insulin sensitivity.  However, the OGTT has 
received much criticism, as a 75-gram glucose dose is not comparable to the macronutrient 
distribution of a typical meal or the subsequent insulin response (86).  Thus in our sample, we 
analyzed glucose and insulin levels following a meal consisting of 347 calories (55% 
carbohydrates, 16% protein and 29% fat) with the intention of eliciting a more typical glycemic 
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response.  At baseline, the mean fasting glucose levels in our samples was 100 mg/dl – the cut 
point indicating impaired fasting glucose. Impaired fasting glucose is clinically interpreted as an 
intermediate state between healthy glucose homeostasis and overt diabetes. At 4 and 10 months, 
mean fasting glucose significantly decreased from baseline levels, such that participants 
transitioned from impaired fasting glucose to normal fasting glucose.  This finding alone implies 
participants improved their overall hepatic insulin sensitivity.   At baseline, 4 months and 10 
months the two hour post meal mean glucose levels returned to fasting levels, indicating our 
sample did not present with impaired glucose tolerance at any time point.  Furthermore, the area 
under the curve for glucose did not change significantly over time, providing further evidence 
that our sample on average did not present with impaired glucose tolerance.   
To gain more insight as to how insulin sensitivity changes over time, we analyzed fasting 
insulin, postprandial insulin and insulin sensitivity indices longitudinally. The total AUC and 
positive iAUC for insulin decreased significantly from baseline to 4 months and baseline to 10 
months. This finding implies a greater release of insulin was required at baseline compared to 4 
and 10 months to uptake the same amount of glucose.   In other words, participants were able to 
improve their overall insulin sensitivity after ingesting the same amount and proportion of 
macronutrients at each time point.  Furthermore, HOMA-IR and Matsuda Index scores both 
significantly improved from baseline to months.   HOMA-IR tends to be more indicative of 
hepatic insulin sensitivity, whereas the Matsuda Index reflects both hepatic and peripheral 
insulin sensitivity.   Therefore it follows that both hepatic and peripheral insulin sensitivity were 
improved from baseline to 4 months and baseline to 10 months in our sample.   
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 Improved insulin sensitivity is especially important in our sample of breast cancer 
survivors, given the prognostic value of insulin for breast cancer recurrence, heart disease and 
type 2 diabetes (53, 60).  To this point, a recent review highlighted the importance of addressing 
the problem of insulin resistance among breast cancer survivors as it may exacerbate co-
morbidities (157).  The breast cancer survivors in our sample were able to improve their insulin 
sensitivity through adhering to a weight management intervention targeting diet and exercise.  
The women in our sample did not achieve the recommended amount of exercise throughout the 
intervention, however we still observed overall improvements in insulin sensitivity, suggesting 
weight loss improve insulin sensitivity regardless of changes in MVPA.  Furthermore, the 
women in our sample were not able to successfully reduce sedentary behavior and thus the effect 
of changing sedentary time could not be assessed in our sample.  We believe future research 
should focus on establishing feasible methods for reducing sedentary time.  Qualitative 
assessments in our sample indicated reducing sedentary time were not perceived as being as 
important as diet or exercise.    
 Weight loss and decreased central adiposity as measured by waist circumference were 
predictive of improved insulin response in prior weight loss studies (32, 68).  In our sample, 
change in weight was not predictive of change in fasting insulin.  However, percent weight loss 
was associated with improved insulin sensitivity as measured by the Matsuda Index.   Physical 
activity levels, sedentary time and change in diet were not predictive of change in fasting insulin 
or insulin sensitivity in our sample.  This finding is not in agreement with other studies that have 
examined the relationship between physical activity levels and insulin sensitivity (158).  
Although the women in our sample significant increased their activity throughout the course of 
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the intervention, they did not increase physical activity to the recommended level and thus the 
lack of predictive quality of physical activity is not surprising.  Furthermore, changes in 
postprandial glycemic control are affected by short-term changes in activity, as evidenced by a 
study by Mikus et al. in which apparently healthy individuals wore continuous glucose monitors 
during three-day periods of high activity and three day periods of low-activity and changes in 
postprandial glucose were observed between the two conditions (159).  Because acute changes in 
activity result in immediate physiologic changes in postprandial glycemic control, it is possible 
changes in activity in our sample were missed due to the 6 month time period between 
postprandial measures. Additionally, changes in total calorie intake throughout the intervention 
were not predictive of changes in insulin sensitivity in our sample.  Chronic energy imbalance, 
particularly through excessive caloric intake has been linked to insulin resistance through the 
promotion of hyperinsulinemia and increased production of triglycerides and subsequent fat 
storage (52). Thus it follows that a decrease in calorie intake may be predictive of improvements 
in insulin sensitivity; however this relationship was not the case in our small sample.   
 The most notable strength of our study was the assessment of postprandial glucose and 
insulin throughout a weight management intervention among a group of overweight and obese 
breast cancer survivors.  The postprandial piece contributes important physiological 
understanding as to the impact our intervention on glycemic control among breast cancer 
survivors. A limitation of our study was the small sample size and the limited generalizability of 
the study findings due to our homogenous sample demographics. Another limitation was the 
inability to determine if changes in sedentary time is a potential predictor of changes in insulin 
resistance.  
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 In conclusion, a weight management intervention among breast cancer survivors can 
successfully reduce fasting insulin, fasting glucose, postprandial insulin and can produce 
sustainable improvements in insulin sensitivity.  Future interventions should include larger 
sample sizes and aim to assess predictors of improved insulin sensitivity among more diverse 
populations of overweight and obese cancer survivors.  
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CHAPTER FOUR 
 
PERCEIVED BARRIERS TO REDUCING SEDENTARY BEHAVIOR WITHIN A 
WEIGHT MANAGEMENT INTERVENTION 
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Abstract: 
Introduction: Sedentary behavior is an emerging health risk for the general population and may 
be especially problematic for breast cancer survivors in terms of recurrence and risk of co-
morbidities.  Interventions to reduce sedentary time among breast cancer survivors have not been 
conducted and barriers to reducing sitting time are unknown.   The purpose of this study was to 
assess perceived barriers to reducing sitting time among breast cancer survivors enrolled in a 
weight management intervention. Methods: Breast cancer survivors who completed a 4 month 
weight loss intervention were encouraged to reduce sedentary time during a 6 month weight 
maintenance phase.  Participants were not successful in significantly reducing sedentary time. In 
order to gain better understanding of perceived barriers to reducing sedentary time the 
participants were contacted by study staff to complete a 26-question survey based on the Theory 
of Planned Behavior including assessments of perceived control, perceived importance, and 
perceived norms and intentions. Experiences with technology were also assessed. Responses 
were recorded and analyzed to determine frequencies, means and representative comments.  
Results:  All participants completed the survey (n=10; age: 51.1±8.6 years; 33.3±4.0 kg/m2).  
Only 30% of participants felt it was very important to reduce sedentary time and the majority 
thought diet and exercise were more important than reducing their sitting time.  Although 60% of 
the women felt they were more aware of the harms of sedentary behavior than the general public, 
they had low levels of perceived control (7.3 on a 10 point scale) of changing these behaviors.  
They also did not have strong intentions of changing their sitting time (6.3 on a 10 point scale). 
Workplace environment was the primary barrier to reducing sedentary time.  Overall, 
participants enjoyed the technology components of the intervention, but it was not enough to 
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produce significant changes in sitting time.  Conclusion: Participants’ perceived importance, 
norms, control and intentions did not support their ability to change sedentary behaviors.  
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Introduction  
Emerging research has linked sedentary behavior to a myriad of health risks including 
obesity, cardiovascular disease, type 2 diabetes, certain types of cancer, and all cause mortality 
(99, 102). In the U.S., breast cancer survivors spend over 65% of waking time in sedentary 
behaviors (e.g. sitting, reclining, laying down) and less than 1% of their waking time engaging in 
moderate to vigorous physical activity (100).  Well established data from observational and 
intervention studies have demonstrated that breast cancer survivors who engage in regular 
moderate to vigorous activity have reduced risk of recurrence and death when compared to 
survivors who do not engage in physical activity (12).  Although regular exercise may reduce 
risk, new findings suggest those who engage in regular exercise may compensate by sitting more 
throughout their day (91).  This finding has also been demonstrated in breast cancer survivors 
(160).   
 Although many observational studies have indicated an association between sitting time 
and health risks, few interventions have targeted a reduction in sedentary time among adults.  
The few interventions that have been conducted have ranged from 6-12 weeks and have shown 
modest reductions in self-reported and objectively measured sitting time (111-113).  No long-
term interventions have been conducted to determine if the reduction in sitting time can be 
maintained over a longer period of time.  Furthermore, only one intervention to our knowledge 
has been conducted outside of the workplace in adults (109). Lastly, no interventions to date 
have tested the feasibility of reducing sedentary behavior within a weight maintenance 
intervention.    
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To address this gap in the literature, we designed an intervention to determine the 
feasibility of reducing sitting time within a weight maintenance intervention among breast cancer 
survivors.  Although participants lost more than and average of 10% of their baseline weight and 
maintain that weight loss throughout a 6 month maintenance phase, the added component of 
reducing sedentary behavior was largely unsuccessful.   
The purpose of this secondary analysis was to assess the perceived barriers to reducing 
sitting time among a group of breast cancer survivors who were enrolled in a weight 
management intervention.  The Theory of Planned Behavior served as the basis for the 
evaluation of this intervention as it is a widely accepted method for assessing behavior change 
(161). The Theory of Planned Behavior includes four main domains:  importance of the 
behavior/attitudes toward the behavior, subjective norms, perceived behavioral control and 
intention to change the behavior.   
 
Methods 
Sample 
 Participants were breast cancer survivors who were enrolled in a 10 month weight 
management intervention and randomized to receive a maintenance intervention aimed at 
reducing sedentary behavior (n=10).  Intervention components are detailed in Chapter 3.  Briefly, 
participants completed a 4 month weight loss intervention and were then randomized to a 6 
month maintenance intervention.  After the four month weight loss period, participants 
randomized to the sedentary behavior intervention received a FitbitZip® activity tracker, an Aria 
Fitbit Smart Scale®  and a Lose It®  account to track their diet.   Participants met bi-weekly via 
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group conference call.  Participants were given individualized calorie goals to optimize weight 
maintenance and were encouraged to complete 225 minutes of MVPA per week.   Participants 
were given three main goals to help reduce sedentary behavior: reduce sedentary behavior by 
replacing sitting activities with light intensity activities; limit television time to less than 90 
min/day; and limit uninterrupted sitting bouts lasting 30 minutes or longer.  Intervention 
materials can be found in Appendix III.   
The interviews were developed and conducted as a part of a Health of the Public course 
for 4th year medical students at The University of Kansas Medical Center.  Dr. Christie Befort 
oversaw the project design and development and I served as the site mentor.  Together, we 
developed and conducted a 26-question survey based on the Theory of Planned Behavior.  
Responses options were based on a four-level Likert scale or a 1-10 level ranking system.  
Following each close-ended question, we asked open-ended questions (e.g. Why? Explain?) to 
gain further insight into their response. The survey questions were designed to assess 
participants’ perceived control, behavioral attitudes and subjective norms as they related to 
changing their sedentary time.  In addition, the survey aimed to assess the participants’ 
experiences with the technology components of the intervention.  The survey can be found in 
Appendix II (page 141).  
Data collection 
 Trained students called each participant to complete a telephone interview survey after 16 
weeks of participation in 6 month maintenance intervention.  Each of the three medical students 
contacted 3-4 participants.  The interviews lasted approximately 20-40 minutes.  Responses were 
recorded in RedCAP, a web-based survey application.    
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Data analysis 
  All survey responses were recorded in RedCAP at the time of the interview and exported 
into Microsoft Excel for data coding and analysis.  Responses were coded by two independent 
sets of trained staff. Qualitative data are reported as mean and standard deviation or frequency of 
responses.  Content analysis was conducted for all open-ended questions.  Representative 
comments were selected for presentation.    
 
Results 
All of the 10 participants that completed the sedentary behavior intervention completed 
the telephone survey.  Participant characteristics at enrollment are listed in Table 4.1.   
Participants lost a mean of 11.3% ± 4.8% of their baseline weight after the weight loss phase and 
11.2% ± 7.8% of their baseline weight after the weight maintenance phase.  According to self-
reported measures, participants did not significantly increase their MVPA from 4 to 10 months.  
Self reported sitting time did not change significantly from 4 months to 10 months on weekdays 
or weekend day.  
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Table 4.1. Participant Characteristics (n=10) 
 Mean ± SD or n (%) Range 
Age (years) 51.1 ± 8.6 42.3-65.2 
BMI (kg/m2) 33.3 ± 4.0 28.1-41.2 
Weight (kg) 91.0 ± 9.2 76.3-104.0 
Waist circumference (cm) 97.8 ± 6.2 83.1-108.3 
Time since diagnosis (years) 3.9 ± 2.2 1.2-7.3 
Cancer stage 
Stage I 
Stage II 
Stage III 
 
4 (40.0%) 
6 (60.0%) 
0 (0%) 
Employment Status 
Unemployed/retired 
Part Time  (< 35 hrs/wk) 
Full Time  (>35 hrs/wk) 
 
3 (30%) 
2 (20%) 
5 (50%) 
Data are presented as mean ± SD or n(%) and range.    
 
 
Table 4.2. Weight Loss and Activity Outcomes (n=10) 
 4 month 10 month 4-10 month change 
 Mean  ± SD Mean ±  SD Mean Δ  ± SD 
Weight loss (% of baseline) 11.3%  ± 4.8% 11.2%  ± 7.8% 0.2%  ± 3.8% 
MVPA (min/week) 94.6  ± 92.4 87.5  ± 96.9 -7.1  ± 78.3 
Work day sitting time (hrs/day) 9.6  ± 2.1 9.8  ± 2.3 0.3  ± 2.8 
Non work day sitting time 8.8  ± 2.4 7.8  ± 1.8 -1.0  ± 2.4 
Data are presented as mean  ± SD.  No significant differences observed from 4 to 10 months. 
 
Survey Results:  
 Frequencies or mean ± SD of responses to the survey questions and the specific 
component of the Theory of Planned Behavior addressed in each question are presented in Table 
4.3.   
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Table 4.3 Sedentary Behavior Survey Responses (n=10)  
Component Survey Question Responses as n(%) or mean(SD) 
  Not at all important 
Slightly 
important 
Moderately 
important 
Very 
important 
Importance How important is it to you to reduce the amount of time your spend sitting? 0 (0%) 1 (10%) 6 (60%) 3 (30%) 
  Much less Somewhat less 
Somewhat 
more 
Much 
more 
Importance How much time and effort do you put into exercise compared to reducing sitting time? 2 (20%) 1 (10%) 3 (30%) 4 (40%) 
Importance  How much time and effort do you put into your diet compared to reducing your sitting time? 1 (10%) 0 (0%) 3 (30%) 6 (60%) 
Norms 
Compared to you, how concerned do you think 
other women your age are about the amount of 
time they spend sitting? 
6 (60%) 2 (20%) 1 (10%) 1 (10%) 
Norms How much time do you believe other women your age spend sitting compared to you? 0 (0%) 2 (20%) 8 (80%) 0 (0%) 
  Mean ± SD Range   
Perceived 
Control  
On a scale from 1-10, with 1 being the least and 
10 being the most, how confident are you that 
you can reduce your sitting time over the next 
two weeks? 
7.3  ± 1.6 5-10   
Perceived 
Control  
On a scale from 1-10, with 1 being the least and 
10 being the most, how much control do you have 
over changing the amount of time you spend 
sitting? 
7.3  ±  2.4 5-10   
Intentions  
On a scale from 1-10, with 1 being the least and 
10 being the most, to what extent do you intend 
to reduce your sitting time as recommended by 
the program in the next 2 weeks? 
6.3  ±  2.0 2-9   
 
Attitude Toward Behavior 
The telephone survey indicated only 30% of participants thought it was very 
important to reduce their sitting time.  The majority of participants reported that exercise 
and diet were more important than reducing their sitting time, with 70% of participants 
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indicating that they put more of their time and effort into exercise and 90% saying they put 
more time and effort into their diet.  
 “I spend somewhat more time on my diet because it's such a good idea to get in all the 
vegetables and eat balanced meals. It's important in getting weight down and keeping 
weight down.” 
 
Subjective Norms 
 The majority of participants (80%) believed that other women their age were less 
concerned about sitting.  Furthermore, 80% of the women believed that women their age 
spend more time sitting.  Overall they commented that other women tend to be less aware 
and less educated about the harms of too much sitting.  
“Most people out there don't have as many issues and they aren't educated on the 
importance of reducing sitting time, even though it's been shown to be helpful for 
multiple conditions. Most Americans sit around and are couch potatoes, and aren't 
aware of the benefits of reducing sitting.” 
 
Perceived Control and Intention 
 The women were asked to rate their confidence as it regarded to reducing their sitting 
time over the next two week period on a scale from 1-10, with 1 being the least and 10 being the 
most confident.  Women reported a mean confidence of 7.3 ± 1.6.  They also reported a mean of 
7.3 ± 2.4 when asked how much control they had over changing their sitting time.  However, 
when women were asked to what extent they intended to change the amount of time they spent 
sitting, the mean rating was a 6.6 ± 2.0 and ranged from 2.0-9.0.  Participants reported they had 
the most control outside of their workplace and they had least control of their sitting at work or 
while driving.   
“I don’t have a lot of control at work and I sit a lot there, even though I wants to be on 
my feet as much as possible.” 
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“If I am at home, I have 100% control. My job requires a lot of sitting because I am a bus 
driver, but I get up and move about when I’m not driving.” 
 
“I have a new job and to do a good job, I have to email and be online and reporting and 
that seems impossible if you're standing. Can't work as fast if you're standing up. 
 
 
 
Table 4.4 Sedentary Behavior Technology Survey Responses (n=10) 
 Phone Computer Both   
How do you access your dashboard or app 
interface? 4 (40%) 3 (30%) 3 (30%)   
 Weight Calories Consumed Steps 
Very Active 
Minutes 
Activity 
log 
Of the following, which component of the 
dashboard or app interface do you pay most 
attention to? 
1 (10%) 0 (0%) 8 (80%) 0 (0%) 1 (10%) 
Which component of the dashboard or app 
interface do you pay next most attention to? 0 (0%) 4 (40%) 1 (10%) 3 (30%) 2 (20%) 
 Never Once per week 
Several times a 
week 
Every day or 
more  
How often do you check your lightly active 
minutes? 3 (30%) 3 (30%)  4 (40%)  
 Yes No    
Do you feel the Fitbit® provides accurate 
feedback about your light activity? 9 (90%) 1 (10%)    
 Not at all useful Slightly useful 
Moderately 
useful Very useful  
How useful was the Fitbit® feedback in 
increasing your light activity? 1 (10%)  5 (50%) 4 (40%)  
 No affect Minor affect Moderate affect Major affect  
How much did tracking your light activity 
affect your behavior? 1 (10%)  6 (60%) 3 (30%)  
What affect did tracking your TV time have 
on decreasing your TV time? 6 (60%) 1 (10%) 2 (20%) 1 (10%)  
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 No difference 
Slightly more 
easy 
Moderately 
more easy 
Much more 
easy  
How much easier has the Aria®  scale made 
it to track your weight? 0 (0%) 1 (10%) 3 (30%) 6 (60%)  
 Much less easy 
Somewhat 
less easy 
Somewhat 
more easy 
Much more 
easy  
How easy is it to use the Lose It account 
compared to paper tracking? 0 (0%) 0 (0%) 1 (10%)  9 (90%)   
 Much less time 
Somewhat 
less time 
Somewhat 
more time 
Much more 
time  
How much time do you spend using the 
Lose It®  app compared to paper tracking? 2 (20%)  3 (30%) 1 (10%) 4 (40%)  
 
Technology  
 Participants reported high satisfaction with the technology component of the program.  
90% of the women thought the Fitbit Zip® activity trackers were useful in increasing their light 
activity time and 90% felt the Fitbit was accurate in tracking their activity levels.  Additionally, 
90% of the women reported the Fitbit Aria Smart Scale® made it easier to track their weight and 
100% of the women said their Lose It® account was easier than keeping a paper food diary.  
“Love the Aria scale! And fitbit! Wifi sync made it easier.  Weighing on analog scale 
didn't sync with app, so couldn't see trends.” 
 
“Everything has a barcode you can scan – it’s the bomb!” 
 
Discussion  
The Theory of Planned Behavior includes assessment of perceived importance and 
beliefs, subjective norms, perceived control, and intentions to make the behavior change.  
The results from our survey indicate participants thought reducing sitting time was of low 
importance compared to dietary and physical activity goals.  Although they felt like they 
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had more knowledge about the harms of too much sitting and thought that they spent less 
time sitting than other adults their age, they reported having only a moderate amount of 
control over the amount of sitting time.  Furthermore, participants did not have strong 
intentions of reducing their sitting time throughout the intervention.  
The most commonly reported barrier to reducing sitting time was workplace 
activities.  Seven of the ten women had full time or part time jobs and three of the women 
were retired or unemployed.  Of the women who were employed, 90% reported work 
related activities as the largest barrier to reducing their sitting time and specifically cited 
computer time, meetings, work environment, confinement to cubicle or desk as barriers 
while at work.  Many of the participants also reported traveling time as a significant barrier 
to reducing their sitting time.  One participant who was a bus driver was unable to move 
around for a substantial part of each work day as she was driving a school bus.  Other 
reported barriers included inclement weather and sitting hobbies (e.g. sewing, 
scrapbooking, reading).   The three women who were not employed most commonly cited 
computer time at home as an important barrier to reducing sitting time.  One participant 
spent most of her time quilting and sewing – both of which she felt she could not do while 
standing.   
 Although participants overwhelmingly enjoyed of the technology components of the 
intervention, it did not appear to enhance their ability to reduce their sitting time. The 
Fitbit® and Lose It® technology components were given to the participants after a 4 month 
weight loss intervention in which they tracked their diet and physical activity manually on 
paper.   Most participants reported the technology made it much easier to track their 
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weight, diet and physical activity throughout the maintenance phase.   However, some 
participants reported they thought it would have been helpful to have more time to 
acclimate to the devices before the maintenance phase began.  Although participants were 
instructed to look at their apps or check the website every day to assess activity, only 40% 
of participants reported doing so.  In fact, two of the women reported never checking their 
lightly active time because they could not access the information easily from their mobile 
phone.   
 The biggest strength of this secondary analysis is the insight gained into the 
perceptions and feelings of women participating in an intervention that attempted to 
reduce sedentary behavior.  Several limitations were present in the analysis.  The 
interviews were conducted four months into the intervention, instead of at the end of the 
intervention and only captured the participants’ opinions at one point in time.  
Furthermore, the interviews were conducted over the phone, which may have limited the 
interpretability of certain responses.   
 In conclusion, reducing sedentary behavior was not as important to participants as 
other components of the weight management program.  Furthermore, participants did not 
feel they had control over their sitting time and their intentions of reducing sedentary time 
were not strong.  In the future, interventions should focus on sedentary time alone without 
the introduction of other lifestyle behaviors.  Furthermore, initiatives are needed to make 
light activity more conducive in the workplace.  Finally, usability of technology should be 
improved to provide participants with easy access to activity data.   
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DISCUSSION AND CONCLUSION 
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Summary of Findings  
 The studies presented in this dissertation aimed to 1) assess the impact of weight loss and 
weight loss maintenance on components of MetS among obese and overweight breast cancer 
survivors, 2) determine relationships between changes in dietary and activity variables and 
changes in the components of MetS, 3) examine differences in fasting and postprandial glucose 
and insulin and measures of insulin sensitivity following the same weight management 
intervention among breast cancer survivors, 4) determine if change in weight, diet or activity 
were predictors of improvements in insulin sensitivity after a weight management intervention, 
5) assess barriers to reducing sedentary behavior within a weight maintenance intervention 
among breast cancer survivors.  
 Overall, the 10 month weight management intervention resulted in marked improvements 
in the components of MetS (except blood pressure) and measures of insulin sensitivity among 
breast cancer survivors.  Associations between changes in dietary and physical activity 
components confirmed what is congruent with the literature regarding weight loss through 
lifestyle changes and MetS. Furthermore, participants were unable to successfully reduce their 
sitting time throughout the intervention.  Low levels of perceived control and little intention of 
changing behaviors were likely the cause of the unchanged sitting time.  
 
Improvements in Metabolic Syndrome After a Weight Management Intervention Among 
Breast Cancer Survivors 
 The effects of a 4 month weight loss intervention and a 6 month weight maintenance 
intervention on changes in components of MetS among overweight and obese breast cancer 
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survivors were examined.   Participants who met criteria for MetS decreased throughout the 
intervention, with 12 (54%) participants meeting criteria at baseline, 9 (41%) participants at 4 
months and 6 (27%) participants at 10 months.  However the change in number of participants 
who met criteria from baseline to 10 months was not significant in this small study. Participants 
lost a mean of 10.7 ± 3.9% of baseline weight after the 4 month weight loss intervention and 
achieved significant improvements in waist circumference (-7.03 cm), fasting glucose (-7.14 
mg/dl), and triglycerides (-22.23 mg/dl).  However, there was significant decrease in HDL-C 
after the 4 month weight loss period (-5.59 mg/dl).  The participants who lost the greatest percent 
of baseline weight also exhibited the greatest decreases in waist circumference (r=0.67), 
decreases in percent calories from fat (r=0.52), and increases in fruit and vegetable intake(r=-
0.54).  Furthermore, decreases in percent calories from fat were associated with decreases in 
serum triglycerides (r=0.454).  Additionally, decreases in fasting glucose were associated with 
increases in MVPA (r=-0.458).  
The 6 month weight maintenance intervention was successful (i.e. they did not regain 
their weight), as participants maintained their 4 month weight loss within a mean of -0.76 kg ± 
3.59 kg.  Our weight loss maintenance results are impressive in light of the literature in this area 
commonly reporting regain after a period of weight loss(45, 162). Although participants did not 
continue to lose significant amounts of weight, they continued to reduce their waist 
circumference throughout the 6 month maintenance phase (-2.76 cm).  HDL-C significantly 
increased (+11.82 mg/dl) during the maintenance phase. Percent weight loss from 4 to 10 months 
was associated with continued decreases in waist circumference (r=0.883).  Increases in percent 
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fat intake from 4 months to 10 months were associated with greater reductions in percent weight 
loss (r=0.572) and waist circumference (r=0.572).  
 
Impact of a Weight Management Intervention on Fasting and Postprandial Measures of 
Insulin and Insulin Resistance Among Breast Cancer Survivors 
 Our results show that a 4 month weight loss intervention successfully reduced both 
fasting insulin (-5.72 mU/l) and fasting glucose (-7.63 mg/dl) among a group of overweight and 
obese breast cancer survivors.  Furthermore, 4 month values for postprandial insulin (AUC and 
iAUC) were significantly reduced by 31.5% and 27.5% respectively and this reduction was 
sustained for the subsequent 6 months of weight maintenance. However, there was no change in 
postprandial glucose at any time point.   Measures of insulin resistance were also significantly 
improved after weight loss and sustained after weight maintenance, as evidenced by marked 
improvements in HOMA-IR (-49%) and Matsuda index scores (+67%) from baseline to 10 
months. 
 Changes in dietary and activity factors did not predict changes in insulin sensitivity. 
Percent weight loss was not associated with change in fasting insulin levels. However, 
improvements in Matsuda Index scores were significantly associated with percent weight loss 
from baseline to 10 months (r=-0.545), whereas changes in fasting insulin (r=0.32) and HOMA-
IR scores (r=0.32) were not significantly association with percent weight loss.   
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Perceived Barriers to Reducing Sedentary Behavior Within a Weight Management 
Intervention  
 We found no evidence no difference between the sedentary behavior group and the 
standard weight maintenance group in their ability to maintain weight loss. In order to better 
understand the perceived barriers to reducing sedentary time among breast cancer survivors, we 
conducted phone interviews based on the Theory of Planned Behavior.  The results for these 
interviews suggested participants felt reducing sedentary time was not as important as diet and 
exercise.  Relative to peers outside the study, they felt they had more knowledge about the health 
impact of too much sedentary behavior and felt they were more active. Participants reported little 
control of their sedentary time. Using the Theory of Planned Behavior as our framework, our 
interviews identified workplace environment as the major barrier to reducing sedentary behavior. 
Participants also reported sitting hobbies like sewing and scrapbooking as significant barriers. 
Furthermore, they did not have strong intentions of reducing their sedentary time.   
 We also assessed experiences with the technology components of the intervention and 
found that participants were highly satisfied with the Fitbit® activity tracker, Aria® smart scale 
and their Lose It® accounts.  While they reported that these tools made them more aware of their 
behaviors, it was not enough to significantly change sedentary behaviors. 
 
Clinical Significance 
 As science progresses and treatments for breast cancer are optimized, the number of long 
term survivors of breast cancer increases (124).  Obesity will continue to be a threat to breast 
cancer survivors. Breast cancer survivors have a unique set of health risks following treatment, 
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of which obesity plays an important role (163).  Metabolic syndrome and insulin resistance are 
both condition that underlie obesity and must be closely monitored after breast cancer treatment 
because a significant amount of evidence suggests they play an important role in the health and 
longevity of these women.  The results of the research presented in this dissertation, suggest 
weight loss through diet and exercise results in improvements in components of MetS and insulin 
resistance and these improvements can be effectively sustained after a period of weight 
maintenance.  This is important for breast cancer survivors who are especially vulnerable to 
obesity and cardiovascular disease.   
 The clinical utility of MetS in the general population has been criticized for a number of 
practical reasons.  First, there are at least sixteen different cutoffs and/or combinations of 
diagnostic criteria used to define MetS (15).  Although efforts have been made to harmonize the 
definition of MetS, there still remains some controversy in literature regarding appropriate 
cutoffs for specific demographic and ethnic groups.  There is not one unifying mechanism that 
can describe the interplay between the components of MetS.  Furthermore, there is no single 
drug that can adequately address all of the components of MetS at the same time, and physicians 
are left to treat all components of MetS on an individual level. All of these factors have resulted 
in frustration for physicians and a consequent lack of diagnosis of MetS in the clinic (164).   
 Regardless of which cutoffs are used, the only successful treatment of MetS as a whole is 
achieving and maintaining healthy weight through lifestyle changes in diet and exercise.  
Although the National Cholesterol Education program recommends Therapeutic Lifestyle 
Change (TLC) as the first treatment for MetS, physicians are more often prescribing drugs than 
lifestyle (22, 165). I would argue that MetS can and should be utilized as a teachable moment in 
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the clinic in which the promotion of healthy lifestyle can play a central role.  Instead of 
reviewing individual components and prescribing specific medications for each component, 
physicians could instead have a more general conversation with their patients about the benefits 
of healthy lifestyle.  
Furthermore, MetS may have particular importance for the clinical implications of breast 
cancer survivors in terms of both breast cancer recurrence and risk of comorbidities (13, 166).  A 
combination of adjuvant breast cancer treatment (167), weight gain after treatment (168), and 
obesity (65) all contribute to the higher prevalence of MetS in breast cancer survivors when 
compared to non-cancer survivors. We found that successful weight loss and weight maintenance 
effectively reduces components of MetS among breast cancer survivors.  However, lifestyle 
change is rarely a part of the conversation between oncologists and their patients (169, 170).  
Survivorship care plans are now becoming a standard of care in cancer centers across the nation; 
however, more research is needed to determine the proper time and delivery of lifestyle 
recommendations for cancer survivors (171).   
 Identifying insulin resistance is a valuable extension of metabolic syndrome that also 
deserves clinical attention.  The Center for Disease Control (CDC) estimates from 2009-2012, 
12.3% of adults age 20 and older had diabetes and 37% had prediabetes – that is nearly half of 
the US population who likely had some degree of impaired insulin sensitivity (172).   
Hemoglobin A1C is the most commonly used diagnostic criteria for diabetes and prediabetes, 
with values between 5.7% and 6.4% indicating prediabetes and values greater than or equal to 
6.5% indicating diabetes (173).  This measurement does not allow clinicians to make any 
definitive diagnosis of insulin resistance.  Furthermore, there is not a universally accepted 
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measure or cutoff for insulin resistance.  Simple mathematical calculations, like HOMA-IR and 
Matsuda Index should be further developed and studied in larger populations so that they can be 
viably used in clinical settings.  This would allow physicians to have a more complete 
understanding of their patients’ physiology and prescribe proper treatment regimens (like 
lifestyle adjustments).  
 Changing sedentary behavior remains a major obstacle among breast cancer survivors. 
Since increased sitting time has been linked to risk of cancer, MetS, and insulin resistance – it is 
in the best interest of clinicians to encourage people to move more and sit less.  The best way to 
deliver this message is yet to be determined. One strategy could be to harness the universal 
dependence on technology.  While the increased time spent in front of screens has led to an 
overwhelming amount of sedentary time (174), we could alternatively use technology to help 
promote active lifestyle through activity trackers like the Fitbit® with added features built-in to 
prompt movement after long periods of uninterrupted sitting.  Our research found changing 
sitting behaviors among breast cancer survivors is difficult because people tend to believe they 
have little control over changing these behaviors.  Furthermore, they believe that other lifestyle 
pursuits like weight loss, dietary changes and exercise are more important than reducing sitting 
time.  When in actuality all of these components play important independent roles in overall 
health.   
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Limitations  
The small sample size is an obvious limitation of the presented research.  As with any 
pilot study, statistical analyses are limited when sample sizes are small.  Specifically, predictive 
models are difficult in small samples, as the general rule of thumb states one predictor should be 
added to the model per 10 participants.  However, effect sizes are robust with a small sample 
sizes. A larger sample size would have increased the power to detect meaningful differences and 
may have provided more insight into the effects of the intervention.  
The inherent issues with self-reported physical activity and dietary data are another 
limitation of the presented research (175). For this study we used self reported data to report 
changes in MVPA, siting time and diet.  Actigraph accelerometers were used at each time point, 
but there were several issues with the functionality of the accelerometer itself and thus could not 
derive meaningful data from the whole sample.  At baseline, 2 participants did not register valid 
wear time and one accelerometer chip was broken.  At 4 months, two participants did not register 
valid wear time, one participant did not return her accelerometer, and one accelerometer chip 
was broken. At 10 months, one participant did not have valid wear time. Of the total sample only 
15 participants had valid accelerometer data for all three time points (n=6 for MAINT + SED 
and n=9 for MAINT). Furthermore, we observed a higher than expected amount of MVPA at 
baseline (>30min/day) as measured by accelerometry. This could have been the case for a few 
reasons.  First, there was up to 30 days between their screening date and their baseline testing 
session.  After screening, participants may have been motivated to make changes in their activity 
or diet so as to get a “jump start” on their weight loss before the program started.  Second, the 
accelerometers were distributed after their baseline testing visit and worn for 8 consecutive days.  
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Although participants were instructed not to change their activity while wearing the 
accelerometer, the Hawthorne Effect may have played a role in the amount of MVPA observed 
at baseline, such that the act of knowing their activity was being monitored impacted their 
activity levels.  A combination of the lapse in time between screening and enrollment and the act 
of wearing the device could have contributed to the high levels of MVPA at baseline.  Despite all 
of this, there was no difference between groups at any time point in accelerometer derived 
sedentary time, light activity or MVPA in the valid sample (n=15) (Figure 5.1) 
Lastly, the generalizability of this pilot study is limited as the recruitment base for the 
breast cancer survivors took place at one clinic in Kansas City. Most participants were white, 
married and well educated – therefore our findings may not be generalizable to all survivors.  
Figure 5.1 Data presented as mean percent of wear time for each level of activity for each group. Dotted lines 
represent MAINT ONLY (n=9). Solid lines represent MAINT + SED (n=6). Sedentary minutes defined as <100 
counts per minute, light activity defined as 100-1951 counts per minute and MVPA defined as ≥ 1952 counts per 
minute 
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Figure 5.1 Accelerometer Derived Activity By Timepoint and Group  (n=15) 
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Future Directions 
 Future research should focus on determining dietary strategies and activity levels 
required to promote optimal metabolic health for breast cancer survivors.  Large-scale 
longitudinal trials are needed to determine the proper amount of calorie reduction and physical 
activity to improve components of MetS and insulin resistance in the long term.  Although this 
research is necessary in the general population, it is specifically needed among breast cancer 
survivors.  
In addition, future interventions and public health efforts should be aimed at determining 
feasible ways to reduce sedentary time.  The message to reduce sedentary time may have been 
diluted by dietary and MVPA recommendations in our intervention. One strategy may be to 
focus solely on reducing sedentary time for a 4-8 week period before the introduction of weight 
loss.  Participants in our sample reported that they spent more of their time and energy focused 
on diet and physical activity when compared to reducing sedentary time because they viewed 
diet and exercise as more important strategies for weight loss and weight maintenance.  They 
were right to do so, as the evidence suggests diet and exercise are the key components of 
successful lifestyle-based weight loss.  Therefore, participants could be given a period of time 
before the intervention began to focus on becoming more aware of sedentary time and then 
setting individualized goals to reduce their sedentary time.  After successful reduction of sitting 
time, the participants could start a weight loss phase, in which they begin to focus on diet and 
exercise while carrying over reduced levels of sedentary time.  
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Future interventions should use recurrence, co-morbidities and death as primary 
endpoints in long-term lifestyle-based weight management programs. Disentangling the 
individual and combined effects of diet and activity on the metabolic health of survivors is 
necessary and requires randomized controlled trials. Dissemination research is also necessary to 
determine ways to best translate these findings to the general public.  
 
Conclusions  
 The work presented in this dissertation suggests a lifestyle-based weight loss and weight 
loss maintenance intervention results in successful improvements of components of metabolic 
syndrome and insulin sensitivity among overweight and obese breast cancer survivors.  Reducing 
sedentary behavior remains an unconquered challenge.  Workplace interventions to reduce 
sedentary time may be an important focus for breast cancer survivors. Most importantly, future 
endeavors should focus on empowering breast cancer survivors to lead healthy lives.   
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Women Standing for Better Health 
You are being asked to take part in this research study because you are a female breast cancer survivor 
and you are currently in an unhealthy weight category (body mass index, BMI>26.9). This study will take 
place through the University of Kansas Medical Center (KUMC) in Kansas City, KS, with Dr. Christie 
Befort as the primary researcher. Two groups of about 15 women will be in the study.  
You can choose whether or not to join, and you may change your mind at any time. There will be no 
penalty to you if you decide not to participate, or if you start the study and decide to stop early. Either 
way, you can still get medical care and services at the University of Kansas Medical Center (KUMC). 
This consent form explains what you have to do if you are in the study. It also describes the possible 
risks and benefits. Please read the form carefully and ask as many questions as you need to before 
making your decision. If you decide to participate, you can continue to ask questions anytime during the 
study. The researchers will tell you if they receive any new information that might cause you to change 
your mind about participating.  
BACKGROUND 
Two-thirds of women in the United States are overweight (BMI 25-29.9 kg/m2) or obese (BMI > 30 
kg/m2). Breast cancer survivors who are overweight or obese have a higher risk of cancer returning, 
along with shorter overall survival after diagnosis. Physical inactivity and sedentary behavior, or too 
much sitting time, is associated with obesity, heart disease and multiple cancers.  
PURPOSE 
Many diet and exercise programs focus on eating a healthy diet and increasing moderate intensity 
exercise in order to lose weight and maintain that weight loss. This study will help us learn if reducing 
sitting time has a positive effect on maintaining weight loss long-term. The results may be useful for 
improving and increasing the success of future weight management programs.  
PROCEDURES 
Months 1-4:  Weight Loss Intervention 
For the first 4 months, you will complete a weight loss program where you will have group meetings 
with a group leader and about 12-15 other breast cancer survivors once per week. The meetings last 
around 60 minutes.  Group meetings are conducted by phone, and are set up as a conference call that 
you will join by calling a toll free number. Once per month, group meetings will be held in person.  You 
may still call in if you are unable to attend in person. 
During the meetings, you will learn about the diet and will receive education on nutrition and physical 
activity. You will also learn ways to change your habits related to diet and exercise, and you will have 
the chance to share with other women in the group and to ask questions and problem-solve about how 
to lose weight and overcome barriers.  You will also learn about how diet and physical activity impacts 
breast cancer risk and have the opportunity to ask questions and share experiences related to being a 
breast cancer survivor.  You will be asked to weigh yourself weekly and to keep track of your diet and 
exercise using a self-monitoring log. You will report this information to your group leader twice per week 
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by email or by phone. Group meetings will be recorded in order to evaluate how the program is working. 
These audio-recordings will be kept confidential and will be destroyed after 5 years.  
 
Diet.  The diet recommendations will be a 1200 to 1500 calorie/day diet consisting of 2 meal 
replacement shakes, 2 entrées available in grocery stores, and 5 one cup servings of fruits and 
vegetables (F/V) per day. During the first 4 months, you will receive the shakes free of charge.  The 
shakes are made by Complete Nutrition LLC, a commercial vendor.  Entrees, fruits, and vegetables will 
not be provided, and you will need to purchase them from the grocery store. A list of acceptable entrees 
will be provided to you at the beginning of the study.  You will also learn about dietary guidelines for 
weight loss to assist you with modifying home-prepared meals to be lower in calories. 
 
The shakes you will be using will be shipped directly to your home by Complete Nutrition, LLC. We 
will share your name, shipping address, and phone number with Complete Nutrition, LLC to allow them 
to ship the shakes directly to you. The only reason Complete Nutrition, LLC will have your name and 
address is to keep track of orders through their online shipping system. Complete Nutrition, LLC will be 
aware that you are in this study but will have no other information about you. They will not contact you or 
use your name for marketing purposes. 
 
Physical Activity.  You will work toward a goal of 225 minutes per week of moderate intensity 
exercise, such as brisk walking. You will work up to this goal slowly, beginning with 15 minutes per day, 
3 days per week. You will be given a physical activity kit to assist you in increasing your weekly exercise 
minutes. Items in this kit include exercise DVDs to assist with aerobic exercise, and a pedometer for you 
to track physical activity levels daily.  
 
Months 4 – 10:  Weight Loss Maintenance Intervention 
For months 4-10, you will be assigned to a treatment group by a process called randomization (like 
flipping a coin).  What happens to you during this part of study will depend on which group you are 
assigned to.  You will have an equal chance of being assigned to either group.  You will find out at 4 
months which group you have been assigned to. 
 
If you are assigned to receive the weight loss maintenance intervention you will have group phone 
meetings every other week for 6 months with the same group of women as the first 4 months.  In-person 
meetings will take place once every 2 months.  These meetings will last about 60 minutes.  During the 
meetings, you will learn to solve problems related to maintaining lifestyle changes and will review 
nutrition and physical activity information.  You will be given a daily calorie goal based on your estimated 
caloric needs to maintain your weight loss, and you will be encouraged to continue to consume 2 
shakes and/or entrees per day.  You will also continue with physical activity with a goal of 225 minutes 
per week of moderate intensity exercise. You will continue to weigh yourself weekly and keep track of 
your diet and exercise. You will report this information to your phone counselor once per week by email 
or by phone. Group meetings will be recorded in order to evaluate how the program is working. These 
audio-recordings will be kept confidential and will be destroyed after 5 years.   
  
If you are assigned to receive the weight loss maintenance plus sedentary behavior intervention you 
will also follow the guidelines of the weight loss maintenance intervention, however your bi-weekly 
meetings will include an additional sedentary behavior component. For months 4-10, you will set 
additional goals to decrease your television time, overall sitting time, and to increase your light intensity 
activity throughout the day.  You will receive a Fitbit Zip activity monitor and a Fitbit Aria Wi-Fi Smart 
Scale to help track your weight and sedentary time.  You will receive thorough instructions from your 
leader as to how to use these devices after your 4 month visit. During the 6 month maintenance phase, 
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you will be asked to sync your Fitbit Zip at least once daily and to weigh yourself on the Fitbit Aria Scale 
at least once weekly.  You will self monitor your sedentary time based on the information provided 
through your Fitbit account.  In addition, your group leader will provide feedback based on your Fitbit 
account and help you to create goals aimed at decreasing your sedentary time.  In addition to 
monitoring your activity, you will be asked to use a diet tracking website to log your daily food intake.  
 
The following data collection visits apply to all participants: 
 
Data Collection Visits 
You will meet in-person with research staff persons 3 different times for data collection.  Before 
beginning the weight loss program, you will attend your first in-person data collection visit (called the 
baseline visit). You will then start the weight loss program. At 4 months, you will attend the second in-
person data collection visit.  The last visit will be at 10 months. These will be private meetings between 
you and the research staff, and will take place in the morning at the University of Kansas Medical Center 
Clinical and Translational Research Unit located in Fairway, KS.  
 
At these visits, the following tests will be completed:  
• Your height, weight, waist circumference, and blood pressure will be measured.  
• You will complete a survey that asks questions about your background, health, diet and physical 
activity behaviors and beliefs, and quality of life.  
• You will be asked questions about your food intake, specifically what your ate and drank during the 
previous day.   
• You will be asked to come to the appointment following an overnight (10-12 hour) fast.  Upon your 
arrival, a small catheter will be placed in your arm by a trained nurse, and a blood sample (≤ 3 
teaspoons) will be collected.  You will then be asked to consume a breakfast meal consisting of 
approximately 350 calories and 50 g carbohydrates. For the next 2 hours, you will be asked to lie still 
on a bed while we will collect a small blood sample (1-2 tablespoons) at 30, 45, 60, 90, and 120 
minutes after you finish the meal.   
• You will be given an accelerometer (looks like a pager), which you will wear around a belt for 7 days 
and return to us by mail in a pre-stamped envelope. Accelerometers will measure how much 
exercise you are doing each day. 
 
In addition to the above tests, at the baseline visit we will collect demographic and medical history 
information and take a picture of you that will be included on the roster given to your group leader.  
 
The in-person data collection visits will last about 3 hours each.  Following each in-person visit, a 
research staff person will call you two times to ask questions about your food intake and to clarify any 
questions about your medical history or survey responses. These phone calls will take about 20-30 
minutes. Finally, at month 5 and 8 you will be interviewed by one of the researchers to ask about your 
feedback on the program, including what you liked and did not like. This interview will last approximately 
15 minutes.  In addition, you may be contacted by the research staff for up to one year after the study to 
clarify your information or discuss future research projects.   
 
 
RISKS 
You may feel some tiredness during your exercise, and your heart rate and blood pressure will increase. 
Under extreme conditions, this can lead to a serious cardiac event, such as a heart attack. The 
possibility of experiencing a serious cardiac event has been estimated to be less than 1 per 20,000 in 
107
adults who exercise. There is also a risk for physical activity related injury, such as a sprained ankle. 
Because of the risks related to starting and participating in a regular exercise program, you have to get 
approval from your physician before starting the study.  
 
If you have had lymph node removal, you are at risk for lymphedema, which is the chronic swelling and 
tightness in the arm or hand due to an accumulation of lymphatic fluid in the soft tissue of the arm. It is 
important to monitor this carefully and, before beginning a strength training program, speak to your 
doctor about any weight limits you might have.  
 
Some pain, swelling, bruising, and bleeding may occur at the site of blood sampling. There is also a 
possibility of infection resulting from the blood draw. You may experience a vasovagal response which 
can include lightheadedness, dizziness, sweating, sudden warmth or coldness, nausea and/or vomiting, 
very rarely visual disturbances or passing out. If this happens we will position your body appropriately, 
and hydrate you with oral fluids. Rarely, thrombosis of the vein may occur resulting in thrombophlebitis 
(swelling of a vein caused by a blood clot). Treatment for thrombophlebitis will mostly consist of applying 
warm pads and supportive care.  
 
Another risk is that you may feel uncomfortable when talking about weight or breast cancer issues. 
Because names are used and audio recorded, there is a risk your confidentiality may be breached.  
 
There may be other risks of the study that are not yet known. You understand that your participation in 
this study is voluntary, and you can choose to end your participation at any time.  
 
NEW FINDINGS STATEMENT 
You will be told about anything new that might change your decision to be in this study. You may be 
asked to sign a new consent form if this occurs.  
 
BENEFITS 
You may benefit by losing weight and maintaining that weight loss.  The information gained in this study 
will help determine decreasing sedentary behavior will help to maintain weight loss. 
 
ALTERNATIVES 
You may choose not to participate in this research study. Some of the other options instead of 
participating include joining a commercially available weight loss program (e.g. Weight Watchers, 
TOPS, etc), using online resources (www.ediets.com, Weight Watchers online, etc), and/or following 
recommendations from the United States Department of Agriculture’s food guide pyramid. Participation 
is voluntary. Deciding not to participate will have no effect on the care or services you receive at the 
University of Kansas Medical Center.   
 
PAYMENT AND COSTS    
You will be need to purchase your own pre-packaged entrees (two per day), available at the grocery 
store in the frozen food section. The cost for these entrees varies greatly, but is estimated at $5.00 per 
day. You will also need to purchase enough fruits and vegetables to eat five one-cup servings per day. 
The intervention sessions, materials, physical activity kits, and the shakes from Complete Nutrition are 
provided at no cost to you.  
 
For data collection visits at baseline and 4 months, you will receive a Target gift card in the amount of 
$50 per visit, and at the 10 month visit, you will receive a $75 Target gift card in return for the time 
required.  For all three visits you will receive a total of $175 in gift cards.  If you withdraw from the study, 
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you will be paid for the completed visits.  Your name and other identifying information, as well as the title 
of this study will be used by offices at KUMC that process payments to research subjects.   
 
IN THE EVENT OF INJURY 
If you have a serious side effect or other problem during this study, you should seek appropriate medical 
care. If it is an emergency, call 911.  You should also contact Dr. Christie Befort at (913) 588-3338.  The 
research team will decide what modifications to the study intervention, if any, is best for you at that time. 
  
INSTITUTIONAL DISCLAIMER STATEMENT 
If you think you have been harmed as a result of participating in research at the University of Kansas 
Medical Center (KUMC), you should contact the Director, Human Research Protection Program, Mail 
Stop #1032, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160. Under 
certain conditions, Kansas state law or the Kansas Tort Claims Act may allow for payment to persons 
who are injured in research at KUMC.   
 
CONFIDENTIALITY AND PRIVACY AUTHORIZATION 
The researchers will protect your information, as required by law.  Absolute confidentiality cannot be 
guaranteed because persons outside the study team may need to look at your study records.  Your 
health information is protected by a federal privacy law called HIPAA.  By signing this consent form, you 
are giving permission for KUMC to use and share your health information.  If you decide not to sign the 
form, you cannot be in the study.   
  
The researchers will only use and share information that is needed for the study.  To do the study, they 
will collect health information from the study activities and from your medical record.  You may be 
identified by information such as name, address, phone, date of birth, social security number, or other 
identifiers.  Your health information will be used at KUMC by Dr. Befort, members of the research team, 
the KUMC Research Institute and officials at KUMC who oversee research, including members of the 
KUMC Human Subjects Committee and other committees and offices that review and monitor research 
studies.   
 
By signing this form, you are giving Dr. Befort and the research team permission to share information 
about you with persons or groups outside KUMC.  Your information will be shared with representatives 
of Complete Nutrition, LLC to allow them to ship the shakes directly to you.  Your information may also 
be shared with U.S. agencies that oversee human research (if a study audit is performed) who may 
make copies of study records for audit purposes.  The purpose for using and sharing your information is 
to make sure the study is done properly and to evaluate the safety and effectiveness of the weight loss 
intervention.   
 
The HIPAA privacy law may not apply to everyone who receives your health information.  Your 
information might not be protected by HIPAA if persons outside KUMC disclose it.  In some cases, there 
may be other laws that protect your information from improper use.   
 
Your permission to use and share your health information will not expire unless you cancel it.  The study 
records kept only by the researcher may not be available to you until the end of the study.  The 
researchers may publish the results of the study.  If they do, they will only discuss group results.  Your 
name will not be used in any publication or presentation about the study.  Finally, you understand that 
the investigator is not prevented from taking steps, including reporting to the proper authorities, to 
prevent serious harm to yourself or others. 
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You have the right to cancel this authorization at any time. Your cancellation must be in writing 
addressed to Dr. Christie Befort, 3901 Rainbow Blvd, MS 1008, Kansas City, KS 66160. You are aware 
that even if you cancel this authorization and withdraw from the study, researchers may continue to use 
and disclose information that was gathered before they received your cancellation.  
 
QUESTIONS 
You have read the information in this form, this study has been explained to you by one of the study 
staff, and your questions have been answered. If you have any more questions, you may contact Dr. 
Christie Befort at 913-588-3338.  If you have any questions about your rights as a research subject, you 
may call 913-588-1240 or write the Human Subjects Committee, University of Kansas Medical Center, 
5012 Wescoe, 3901 Rainbow Blvd, Kansas City, Kansas 66160-7700. 
 
SUBJECT RIGHTS AND WITHDRAWAL FROM THE STUDY 
You may stop being in the study at any time. Your decision to stop will not prevent you from getting 
treatment or services at KUMC or the medical center where you receive your cancer care.  The entire 
study may be discontinued for any reason without your consent by the investigator conducting the study.  
 
CONSENT 
Dr. Befort or the other research team has given you information about what will be done in this research 
study. They have explained what will be done and how long it will take. They explained any 
inconvenience, discomfort or risks that may be experienced during this study. You are aware that you 
may refuse to answer any questions or you may stop participating in the study at any time. Your 
participation will have no effect upon the medical care or treatment you receive in the future from your 
health clinic. You may have this form read to you if it would help your understanding of this study. By 
signing this form, you say that you freely and voluntarily consent to participate in this research study. 
You will be given a signed copy of the consent form to keep for your records. 
 
 
___________________________________    
Print Participant’s Name       
 
____________________________________ _______ __________________ 
Signature of Participant     Time  Date 
 
____________________________________ 
Print Name of Person Obtaining Consent 
 
____________________________________ _______ __________________ 
Signature of Person Obtaining Consent  Time   Date 
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Permission to Contact for Future Research 
 
Please check only one of the two boxes below 
 
In the future, Dr. Befort and researchers at KUMC will be conducting additional studies which may apply 
to you.  A separate consent would be obtained at the time of your participation in any additional studies. 
Please check one of the two boxes below to indicate whether or not you are willing to have us contact 
you when such future studies come up. 
 
       Yes, I am willing to be contacted about future studies for which I might be eligible.   
 
       No, I do not want to be contacted about future studies for which I might be eligible.  
  
 
____________________________                                      ________________ 
         Participant’s Signature                                                       Date 
 
 
Use of Data and/or Blood Samples for Future Research 
 
Please check only one of the two boxes below 
 
       I agree to allow the use of my data and/or blood samples collected during this study to be used for 
future research that is unrelated to this study.  Specifically, the data will be kept for 25 years and will be 
de-identified to prevent any identification back to you.  The blood samples will be stored for 10 years.  
These samples will likely be used for future analysis of weight loss and breast cancer biomarkers that 
have not yet been identified or are currently unable to be measured.  The use and disclosures of 
personal information listed in the consent form also apply to the saved data and/or blood samples.  
However, at any time, I can request that the data and/or blood samples be destroyed if I change our 
mind.  If this occurs, I will provide a written request to Dr. Befort at the address listed below.  Lastly, I 
understand that Dr. Befort can use and share information that was gathered before this request was 
received. 
 
Christe Befort, PhD 
University of Kansas Medical Center, MS 1008 
3901 Rainbow Blvd 
Kansas City, KS 66160 
 
 
                                      
          
       I request my data and/or blood samples collected during this study to NOT be used for any future 
research that is unrelated to this study.  I understand that I can still participate in this study if I refuse to 
have the data and/or blood samples retained. 
 
 
____________________________                                      ________________               
          Participant’s Signature                                                       Date                                                   
  
111
APPENDIX II 
SCREENING FORMS AND ASSESSMENT SURVEYS 
112
www.project-redcap.org
Chart Screen
Contact Information
First Name __________________________________
Last Name __________________________________
Primary Phone Number __________________________________
Other Phone Number __________________________________
Email Address __________________________________
Chart Screen Criteria
BrCa Stage (TNM) __________________________________
Eligible based on staging? Yes
No
(Stage I-III)
Date of last treatment __________________________________
Eligible based on date of last treatment? Yes
No
(greater/equal to 3 mo since last treatment)
Date of qualifying diganosis (most recent)? __________________________________
Eligible based on date of diagnosis? Yes
No
(3 mo - 10 years)
Chart Weight __________________________________
(lbs)
Chart Height __________________________________
(inches)
Chart BMI __________________________________
Eligible based on chart BMI? Yes
No
(25-46)
Chart states use of metformin, glipizides, or insulin? Yes
No
List drug used: __________________________________
Diagnosis of type 1, type 2 or prediabetes? Yes
No
List diganosis: __________________________________
Eligible based on use of medications/diagnosis of Yes
diabetes? No
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Chart smoking history Past smoker
Current smoker
Never smoked
List other major medical conditions potentially
preventing eligibility (i.e. lung disease, diagnosis
of heart disease or other co-morbidities) __________________________________
Addtional Comments: __________________________________
Eligible based on chart screen? Yes
No
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Pre Screen
Today's Date __________________________________
Date of Birth __________________________________
Age __________________________________
Eligible based on age? Yes
No
(< 75)
Weight - Self Report __________________________________
(lbs)
Height - self report __________________________________
(inches)
BMI - Self Report __________________________________
Eligible based on BMI? Yes
No
(27-45)
Have you gained more than 10 lb in the last 3 months? Yes
No
Comments __________________________________
Have you lost more than 10 lbs in the past 3 months? Yes
No
Comments __________________________________
Eligible based on gain/loss? Yes
No
The following questions ask you to think about the activities you have done on a typical week during the past month
and the average time per week you spent doing each activity.  If you participate in any of the activities less than
once per week, your response should be no.  
In a typical week in the past month, did you spend Yes
time walking for exercise? No
If yes, how many minutes did you spend per week? 1-15
16-30
31-45
46-60
61-75
76-90
>90
In a typical week in the past month, did you spend Yes
time jogging (slower than 10 minutes/mile)? No
If yes, how many minutes did you spend per week? 1-15
16-30
31-45
46-60
61-75
76-90
>90
In a typical week in the past month, did you spend Yes
time running (10 minutes/mile or faster)? No 115
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If yes, how many minutes did you spend per week? 1-15
16-30
31-45
46-60
61-75
76-90
>90
In a typical week in the past month, did you spend Yes
time playing tennis, squash, racquetball? No
If yes, how many minutes did you spend per week? 1-15
16-30
31-45
46-60
61-75
76-90
>90
In a typical week in the past month, did you spend Yes
time bicycling (including stationary machine)? No
If yes, how many minutes did you spend per week? 1-15
16-30
31-45
46-60
61-75
76-90
>90
In a typical week in the past month, did you spend Yes
time lap swimming? No
If yes, how many minutes did you spend per week? 1-15
16-30
31-45
46-60
61-75
76-90
>90
In a typical week in the past month, did you spend Yes
time doing other aerobic exercise (aerobic dance, ski No
or stair machine, ect)?
If yes, how many minutes did you spend per week? 1-15
16-30
31-45
46-60
61-75
76-90
>90
In a typical week in the past month, did you spend Yes
time doing other vigorous activities? No
If yes, how many minutes did you spend per week? 1-15
16-30
31-45
46-60
61-75
76-90
>90
In a typical week in the past month, did you spend Yes
time doing weight training or resistance exercises? No 116
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If yes, how many minutes did you spend per week? 1-15
16-30
31-45
46-60
61-75
76-90
>90
In a typical week in the past month, did you spend Yes
time doing low intensity exercise (yoga, stretching, No
toning)
If yes, how many minutes did you spend per week? 1-15
16-30
31-45
46-60
61-75
76-90
>90
Total time spent active per week (excluding low __________________________________
intensity exercise):
Comments __________________________________
Eligible based on time spent active? Yes
No
(< 90 min/wk)
Can you currently walk briskly unassisted for at Yes
least 10 minutes, for example, can you walk six No
blocks briskly without stopping?
Comments __________________________________
Eligible based on ability to walk? Yes
No
Eligible based on pre-screen? Yes
No
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Full Screen
Weight/Diet History
Are you currently participating in any other weight Yes and willing to discontinue current treatment
loss treatment? Yes and not willing to discontinue current
treatment
No
Comments __________________________________
Eligible based on participation in weight loss Yes
treatment? No
Over the past 6 months, have you taken any weight Yes and willing to stop using this medication
loss medications, or other medications that affect Yes and not willing to stop using this medication
metabolism (ex. phentermine, steroids, ect)? No
Comments __________________________________
Eligible based on use of metabolism altering Yes
medications? No
Do you have food allergies or intolerances, or are Yes
you currently on any special diet regimens (taking No
metabolic altering products such as Metabolife,
macrobiotic or vegetarian diets, ect)?
Comments __________________________________
Eligible based on diet regualtions? Yes
No
Medical History
Do you have a bone or joint problem (for example, Yes
back, knee or hip) that could be made worse by a No
change in your physical activity?
Comments __________________________________
Do you have any pending joint replacements? Yes
No
Comments __________________________________
Eligible based on joint health? Yes
No
Do you have congestive heart failure or other cardiac Yes
conditions? No
If yes, describe: __________________________________
Do you feel pain in your chest when you do physical Yes
activity? No
If yes, describe: __________________________________
In the past month, have you had chest pain when you Yes
were not doing physical activity? No
118
www.project-redcap.org
If yes, describe: __________________________________
Do you lose your balance because of dizziness or do Yes
you ever lose consciousness? No
If yes, describe: __________________________________
Eligible based on cardiac history? Yes
No
Have you been diagnosed with any other cancer (other Yes
than non-melanoma skin cancer) within the past five No
years?
If yes, describe: __________________________________
Eligible based on diganosis of other cancers? Yes
No
Do you have any lung diseases? Yes
No
If yes, describe: __________________________________
Eligible based on pulmonary history? Yes
No
Have you ever had bariatric surgery (gastric bypass, Yes
banding or "stomach stapling")? No
Comments __________________________________
Eligible based on bariatric surgery history? Yes
No
Please list any other diganosed medical
conditions/events including any medications taken
for these conditions.  __________________________________
Comments __________________________________
Eligible based on other major medical events? Yes
No
Have you ever been diagnosed with type 1, or type 2, Yes
or pre-diabetes? No
Comments __________________________________
Do you currently take insulin, metformin or Yes
glipizides? No
Comments __________________________________
Eligible based on diagnosis of diabetes or use of Yes
medications for diabetes? No
Do you currently smoke, or do you have a history of Never smoked
smoking in the past? Past smoker
Current smoker
Comments (If you are a past smoker, is this a good
time for you to participate in a weight management
study?) __________________________________
Eligible based on smoking history? Yes
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Health Screening Questions 
In the past year, have you ever drunk or used drugs Yes
more than you meant to? No
Comments __________________________________
Have you felt you wanted or needed to cut down on Yes
your drinking or drug use in the past year? No
Comments __________________________________
Eligible based on substance abuse? Yes
No
Have you been treated for a psychological disorder or Yes
substance abuse in the past 6 months? No
If yes, describe: __________________________________
Did you receive a diagnosis? Yes
No
If yes, what was your diagnosis? __________________________________
Eligible based on psych history? Yes
No
Do you often feel you can't control how much you eat? Yes
No
Comments __________________________________
Do you often eat, within any 2 hour period, what most Yes
people would regard as an unusually large amount of No
food (if yes, refer to unusually large amount of
food)?
Comments __________________________________
Eligible based on binge eating? Yes
No
Availability 
Do you plan to spend frequent time out of town during Yes
the next 10 months? No
Comments __________________________________
Will you have a working home phone or cell phone and Yes
computer continually for the next 10 months? No
Comments __________________________________
Eligible based on availability? Yes
No
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Final Eligibility
Eligible based on BrCa history form? Yes
No
Comments __________________________________
Screened positive for depression using PHQ-9? Yes
No
Comments __________________________________
Eligible based on PHQ-9 Yes
No
Comments __________________________________
Physician Consent received? Yes
No
Comments __________________________________
Consent form signed? Yes
No
Comments __________________________________
Completed orientation visit? Yes
No
Comments __________________________________
Completed baseline testing and randomized? Yes
No
Comments __________________________________
Lost after initially eligible? Yes
No
Check applicable reason: No reason givien/lost contact
Could not attend orientation
Too busy
Not interested in food plan
Scheduling conflicts
Not interested in group calls
"Personal reasons"
Too much travel
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Breast Cancer History
Date of most recent breast cancer dianogisis __________________________________
(Month/Year)
Breast Left
Right
Both
Stage of most recent breast cancer at diagnosis: __________________________________
(TNM and/or Anatomical Stage (0-IIIc))
Original breast cancer ER+? Yes
No
Currently using antihormone therapy? Yes
No
Current antihormone therapy type: __________________________________
Past use of anti hormone therapy? Yes
No
Past antihormone type: __________________________________
Stop date: __________________________________
(Month/Year)
Radiation therapy Yes
No
Stop date: __________________________________
(Month/Year)
Chemotherapy Yes
No
Chemotherapy type(s): __________________________________
Stop date: __________________________________
(Month/Year)
Surgery history (check all that apply) Lumpectomy
Mastectomy
None
Unknown
Lumpectomy date: __________________________________
(Month/Year)
Mastectomy date: __________________________________
(Month/Year)
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Demographics
Please complete the survey below.
Thank you!
1) Screening ID __________________________________
2) Highest education level completed Less than high school
high school/GED
Some college or associate's degree
Bachelor's degree
Master's degree
Doctoral level degree
3) Ethnicity Hispanic or Latino
Not Hispanic or Latino
Unknown
4) Race African American
American Indian or Alaskan Native
Asian
Native Hawaiian or other Pacific Islander
White
Unknown
5) Marital Status Married
Co-habitating
Divorced or separated
Single
Widowed
6) Are you currently employed? Yes, full time (35 hours per week or more)
Yes, part time (less than 35 hours per week)
No
7) What is your occupation? __________________________________
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 Sedentary Behavior and Weight Loss Maintenance for Breast Cancer Survivors 
PROTOCOL # 0192 
Time of Draw/Meal Blood draw completed? Initial 
Fasting 
Draw 
Time Due: 
Actual Time: 
  Yes   
  No   If no; explain:  
Meal 
Consumed 
(should take 
10 minutes) 
Time to Start Meal: 
Actual Time Started Meal: 
 Comments: 
30 Minutes 
Post-Meal 
Time Due: 
Actual Time: 
  Yes   
  No   If no; explain:  
45 Minutes 
Post-Meal 
Time Due: 
Actual Time: 
  Yes   
  No   If no; explain:  
60 Minutes 
Post-Meal 
Time Due: 
Actual Time: 
  Yes   
  No   If no; explain:  
90 Minutes 
Post-Meal 
Time Due: 
Actual Time: 
  Yes   
  No   If no; explain:  
120 
Minutes 
Post-Meal 
Time Due: 
Actual Time: 
  Yes   
  No   If no; explain:  
Nurse’s Signature:  _________________________________________   Date ___________________     
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Anthropormorphics
Date of last food ingestion: __________________________________
Time of last food ingestion: __________________________________
Comments: __________________________________
Have you consumed caffeine or coffee within the last Yes
12 hours? No
Comments: __________________________________
Have you exercised within the past 24 hours? Yes
No
Comments: __________________________________
Weight
Fasting Weight 1 __________________________________
(lbs (###.#))
Fasting Weight 2 __________________________________
(lbs (###.#))
Height (Criteria: Measure height twice; must be < 2 cm difference. Take 3rd height
measurement if first 2 do not meet criteria. Do not delete any measurements.)
Height 1 __________________________________
(cm (###.#))
Height 2 __________________________________
(cm (###.#))
Height 3 __________________________________
(cm (###.#))
Waist Circumference (Criteria: < 2 cm; 3 measurements)
Waist Circumference 1 __________________________________
(cm (###.#))
Waist Circumference 2 __________________________________
(cm (###.#))
Waist Circumference 3 __________________________________
(cm (###.#))
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Resting Blood Pressure
**Must be taken in supine position at rest for 5 minutes prior 
(Criteria: Take 2 BP; SBP < 5 mmHg difference and DBP < 5 mmHg difference. Take a 3rd BP if
first two do not meet criteria. Do not cross out any of the 3 BPs.) 
Resting Blood Pressure 1: Systolic __________________________________
(mm Hg)
Resting Blood Pressure 1: Diastolic __________________________________
Resting Blood Pressure 2: Systolic __________________________________
(mm Hg)
Resting Blood Pressure 2: Diastolic __________________________________
Resting Blood Pressure 3: Systolic __________________________________
(mmHg)
Resting Blood Pressure 3: Diastolic __________________________________
Systolic higher than 140? Yes
No
(If over 140 have ppt sit for 5 minutes before
taking next reading. Instruct ppt to follow up
with PCP regarding high BP. )
Diastolic higher than 80? Yes
No
(If over 80 have ppt sit for 5 minutes before
taking next reading. Instruct ppt to follow up
with PCP regarding high BP. )
If higher than 140/80, did you instruct participant yes
to follow up with PCP? no
N/A
If blood pressure is 160/80 and not currently
treated, alert study staff before beginning draw.
Comments: __________________________________
Did participant take usual blood pressure medications? Yes
No
Not on meds
Select cuff size used Small adult
Adult
Large adult
Thigh
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General Medical History
Have you ever been diagnosed with any cancers other Yes
than breast cancer? No
Description __________________________________
Date Diagnosed: __________________________________
((month/year))
Date Treatment Completed: __________________________________
((month/year))
Do you have immediate family members who are blood Yes
relatives, including parents, sibling, children, who No
have been diagnosed with any cancers (including
breast and ovarian cancer)?
Family Members and Type: __________________________________
Age of diagnosis: __________________________________
Additional Comments __________________________________
Have you ever been told by a doctor that you have Yes
high blood pressure? No
Start Date: __________________________________
((month/year))
End Date (if applicable): __________________________________
((month/year))
Are you currently taking medications for high blood Yes
pressure? No
When was the last time your blood pressure was __________________________________
checked by a health professional?
Was it elevated? Yes
No
Don't Know
What level was it at that time? __________________________________
Additional Comments: __________________________________
Has your doctor ever told you that you have any Yes
cardiovascular diseases or disorders? (i.e. heart No
attack, heart surgery, heart murmur, angioplasty,
pacemaker, arrythmias, stroke, heart valve disease,
lower limb edema, etc.)
Description: __________________________________
Start Date: __________________________________
((month/year))
End date (if applicable): __________________________________
When was the last time your cholesterol was checked __________________________________
by a health professional?
Was it elevated? Yes
No
Don't know
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What level was it at that time? __________________________________
Have you had any close blood relatives who had a Yes
heart attack or heart surgery before age 55 (father No
or brother) or age 65 (mother or sister)?
Family members and type: __________________________________
Age of diagnosis: __________________________________
Additional comments: __________________________________
Has your doctor ever told you that you have any lung Yes
diseases or disorders? (i.e. dyspnea/shortness of No
breath, asthma, pneumonia, bronchitis, etc.)?
Description: __________________________________
Start Date: __________________________________
End date (if applicable): __________________________________
Additional comments: __________________________________
Has your doctor ever told you that you have any Yes
diseases or disorders related to the liver, bile No
ducts, gallbladder, or pancreas? (i.e. cirrhosis,
hepatitis, pancreatitis, gall stones, etc.)
Description: __________________________________
Start Date: __________________________________
End date (if applicable): __________________________________
Additional Comments: __________________________________
Has your doctor ever told you that you have any Yes
gastrointestinal diseases or disorders? (i.e. No
irritable bowel syndrome, diverticular disease,
colitis, etc.)
Description: __________________________________
Start Date: __________________________________
End date (if applicable): __________________________________
Additional Comments: __________________________________
Has your doctor ever told you that you have any Yes
diseases or disorders related to the thyroid (i.e. No
hyperthyroid, hypothyroid, goiter, etc.)?
Description: __________________________________
Start date: __________________________________
End date (if applicable): __________________________________
Additional Comments: __________________________________
Has your doctor ever told you that you have diabetes Yes
or pre-diabetes? No
Pre-diabetes
Start Date: __________________________________ 128
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When was the last time your fasting blood sugar was __________________________________
checked by a health professional?
Was it elevated? Yes
No
Don't know
What was the level at that time? __________________________________
On average, how often do you monitor your blood Several times per day
glucose? Once per day
At least once per week
At least once per month
Only when I go to the doctor
Never
I have never been diagnosed with diabetes or
pre-diabetes
Additional Comments: __________________________________
Has your doctor ever told you that you have any other Yes
endocrine or metabolic diseases/disorders? (i.e. No
osteoporosis, hypoglycemia, etc.)?
Description: __________________________________
Start Date: __________________________________
End date (if applicable): __________________________________
Additional Comments: __________________________________
Has your doctor ever told you that you have Yes
arthritis, or do you experience pain in one or more No
of your joints (arthralgia)?
Description: __________________________________
Start Date: __________________________________
End date (if applicable): __________________________________
Additional Comments: __________________________________
Have you ever been treated for any mood disorders Yes
(i.e. depression, anxiety, etc.)? No
Description: __________________________________
Start Date: __________________________________
End date (if applicable): __________________________________
Additional Comments: __________________________________
Do you currently smoke, or do you have a history of Current smoker
smoking? Past smoker
Never smoked
Start date: __________________________________
End date (if applicable): __________________________________
How many cigarettes do you smoke now, or did you __________________________________
smoke in the past? ((number per day/week/month/year))
Years smoked: __________________________________ 129
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Additional Comments: __________________________________
Do you ever drink alcoholic beverages? Yes
No
If yes, how often do you drink? Daily or almost every day
At least once per week
At least once per month
Once or twice per year
If daily, how many drinks do you have per day? __________________________________
If weekly, how many drinks do you have per week? __________________________________
Additional Comments: __________________________________
Have you ever been told by a doctor that you have any Yes
other medical diseases or disorders that we have not No
already covered?
Description: __________________________________
Start Date: __________________________________
End date (if applicable): __________________________________
Have you ever been diagnosed with lymphedema? Yes
No
Additional Comments: __________________________________
If no, have you ever noticed that one hand, lower
arm, or upper arm was larger than the other? __________________________________
If yes, have you ever received treatment?  Describe: __________________________________
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Medication Record
Medication Name __________________________________
Amount Taken __________________________________
Reason Taken __________________________________
Frequency __________________________________
(times per day/week/month/year)
Start Date __________________________________
((Month/Year))
Medication Name __________________________________
Amount Taken __________________________________
Reason Taken __________________________________
Frequency __________________________________
(times per day/week/month/year)
Start Date __________________________________
((Month/Year))
Medication Name __________________________________
Amount Taken __________________________________
Reason Taken __________________________________
Frequency __________________________________
(times per day/week/month/year)
Start Date __________________________________
((Month/Year))
Medication Name __________________________________
Amount Taken __________________________________
Reason Taken __________________________________
Frequency __________________________________
(times per day/week/month/year)
Start Date __________________________________
((Month/Year))
Medication Name __________________________________
Amount Taken __________________________________
Reason Taken __________________________________
Frequency __________________________________
(times per day/week/month/year)
Start Date __________________________________
((Month/Year))
Medication Name __________________________________
Amount Taken __________________________________ 131
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Modifiable Activity Questionnaire
Please complete the survey below.
Thank you!
Please the box of all activities that you have done during the past 7 days.  
Sunday Monday Tuesday Wednesday Thursday Friday Saturday
Aerobics Dance/Step Aerobics
Badminton
Basketball
Bicycling (indoor/outdoor)
Bowling
Calisthenics/Toning Exercises
Canoeing/Rowing/Kayaking
Dancing (square, line, ballroom)
Elliptical trainer
Fencing
Fishing
Football/Soccer
Gardening/yardwork
Golf
Hiking
Horseback riding
Hunting
Jogging (outdoor, indoor)
Jumping Rope
Martial Arts (karate, judo)
Pilates
Raquetball/Handball/Squash
Rock climbing
Scuba Diving
Skating (roller, ice, blading)
Snow Shoeing
Snow skiing (downhill)
Snow skiing (cross country,
Nordic Track)
Softball/Baseball
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Stairmaster
Strength/Weight Training
Swimming (laps, snorkeling)
Tai Chi
Tennis
Volleyball
Walking for Exercise (outdoor,
indoor, treadmill)
Water Aerobics
Yoga
Other
Enter the total number of minutes that you spent __________________________________
doing aerobic dance/step aerobics each day that you (Example: (Monday - 30 minutes, Wednesday - 30
checked above. minutes))
Enter the total number of minutes that you spent __________________________________
doing badminton each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
doing basketball each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
doing bicycling (indoor,outdoor) each day that you (Example: (Monday - 30 minutes, Wednesday - 30
checked above. minutes))
Enter the total number of minutes that you spent __________________________________
bowling each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
doing calisthenics/toning exercises each day that you (Example: (Monday - 30 minutes, Wednesday - 30
checked above. minutes))
Enter the total number of minutes that you spent __________________________________
canoeing/rowing/kayaking each day that you checked (Example: (Monday - 30 minutes, Wednesday - 30
above. minutes))
Enter the total number of minutes that you spent __________________________________
dancing (square, line, ballroom) each day that you (Example: (Monday - 30 minutes, Wednesday - 30
checked above. minutes))
Enter the total number of minutes that you spent __________________________________
doing the elliptical trainer each day that you (Example: (Monday - 30 minutes, Wednesday - 30
checked above. minutes))
Enter the total number of minutes that you spent __________________________________
fencing each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
fishing each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
doing football/soccer each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
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Enter the total number of minutes that you spent __________________________________
doing gardening or yardwork each day that you checked (Example: (Monday - 30 minutes, Wednesday - 30
above. minutes))
Enter the total number of minutes that you spent __________________________________
golfing each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
hiking each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
horseback riding each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
hunting each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
jogging (outdoor,indoor) each day that you checked (Example: (Monday - 30 minutes, Wednesday - 30
above. minutes))
Enter the total number of minutes that you spent __________________________________
jumping rope each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
doing martial arts (Karate, Judo) each day that you (Example: (Monday - 30 minutes, Wednesday - 30
checked above. minutes))
Enter the total number of minutes that you spent __________________________________
doing pilates each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
doing raquetball, handball or squash each day that (Example: (Monday - 30 minutes, Wednesday - 30
you checked above. minutes))
Enter the total number of minutes that you spent rock __________________________________
climbing each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
scuba diving each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
skating (roller, ice, blading) each day that you (Example: (Monday - 30 minutes, Wednesday - 30
checked above. minutes))
Enter the total number of minutes that you spent snow __________________________________
shoeing each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent snow __________________________________
skiing (downhill) each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent snow __________________________________
skiing (cross country, Nordic Track) each day that (Example: (Monday - 30 minutes, Wednesday - 30
you checked above. minutes))
Enter the total number of minutes that you spent __________________________________
doing softball/baseball each day that you checked (Example: (Monday - 30 minutes, Wednesday - 30
above. minutes)) 134
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Enter the total number of minutes that you spent __________________________________
doing the stairmaster each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
doing strength/weight training each day that you (Example: (Monday - 30 minutes, Wednesday - 30
checked above. minutes))
Enter the total number of minutes that you spent __________________________________
swimming (laps, snorkeling) each day that you checked (Example: (Monday - 30 minutes, Wednesday - 30
above. minutes))
Enter the total number of minutes that you did Tai __________________________________
Chi each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
doing tennis each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
doing volleyball each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
walking for exercise (outdoor, indoor, treadmill) (Example: (Monday - 30 minutes, Wednesday - 30
each day that you checked above. minutes))
Enter the total number of minutes that you spent __________________________________
doing water aerobics each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
doing yoga each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
Enter the total number of minutes that you spent __________________________________
doing other activity each day that you checked above. (Example: (Monday - 30 minutes, Wednesday - 30
minutes))
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Name: ______________________________________    Time Point: ________ 
Think about a usual week.  In the table below, please indicate the total number of hours and minutes per day 
you spend doing each of the activities listed.  There is space to answer for a typical work day and non-work 
day.  Please try to remember as specifically as possible.  Please do not record time twice in different 
categories: for example, if you were reading while watching TV, only report that time under one category. 
Work day Non-work day 
Sleeping/trying to sleep ___ hr  ___min ___ hr  ___min 
Sitting while working ___ hr  ___min ___ hr  ___min 
Sitting while using a computer (not at work) or video game ___ hr  ___min ___ hr  ___min 
Sitting while watching TV or movies ___ hr  ___min ___ hr  ___min 
Sitting during transportation (not including bicycles) ___ hr  ___min ___ hr  ___min 
Sitting while talking, texting, or other socializing ___ hr  ___min ___ hr  ___min 
Sitting while reading, sewing, or doing other 
activities/hobbiesDescribe: __________________ 
___ hr  ___min ___ hr  ___min 
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Technology Survey
Do you use a smartphone on a daily basis Yes
(i.e.android, iphone, blackberry)? No
Check all methods that you use to track your weekly Desktop Computer
data and/or food diaries. Laptop Computer
Tablet (i-pad, Kindle Fire, Nook, ect)
Smartphone
Pen and paper
Other
If other, please type the method you use: __________________________________
Check all websites/applications you use to help track Lose it!
your weekly data and/or food diaries. My Fitness Pal
Calorie King
Fitday.com
Myplate.com
Sparkpeople.com
Myfatsecret.com
Other
I do not use websites or applications.
If other, please type the website or application you __________________________________
use:
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Phone Survey
Record ID __________________________________
How important is it to you to reduce the amount of Not at all important
time you spend sitting? Slightly important
Moderately important
Very important
Explain. __________________________________
How much time and effort do you put into exercise Much less
compared to reducing sitting time? Somewhat less
Somewhat more
Much more
Why? __________________________________
How much time and effort do you put into your diet Much less
compared to reducing sitting time? Somewhat less
Somewhat more
Much more
Why? __________________________________
Compared to you, how concerned do you think other Much less concerned
women your age are about the amount of time they Slightly less concerned
spend sitting? Slightly more concerned
Much more concerned
Explain. __________________________________
How much time do you believe other women your age Much less
spend sitting compared to you? Somewhat less
Somewhat more
Much more
Explain __________________________________
On a scale from 1-10, with 1 being the least and 10 __________________________________
being the most, how confident are you that you can
reduce your sitting time over the next two weeks?
Explain. __________________________________
On a scale from 1-10, with 1 being the least and 10 __________________________________
being the most, how much control do you have over
changing the amount of time you spend sitting?
Explain. __________________________________
In which area of your life do you feel you have the __________________________________
most control over changing the amount of time you
sit? (For example: at work, computer or video game,
TV or movies, transportation, socializing- talking,
texting, hobbies, other).
Explain. __________________________________
In which area of your life do you feel you have the __________________________________
least control over changing the amount of time you
sit?
Explain __________________________________
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What would make it easier for you to spend less time
sitting? __________________________________
Explain. __________________________________
What would make it difficult or prevent you from
reducing the amount of time you spend sitting? __________________________________
Explain. __________________________________
On a scale from 1-10, with 1 being the least and 10 __________________________________
being the most, to what extent do you intend to
reduce your sitting time as recommended by the
program in the next 2 weeks?
Explain. __________________________________
How do you access your dashboard or app interface? Phone
Computer
Both
Explain. __________________________________
Which component of the dashboard or app interface do
you pay most attention to? __________________________________
Of the following, which component of the dashboard or Weight
app interface do you pay most attention to? Calories consumed
Steps
Very active minutes
Activity graph
Explain. __________________________________
Which component of the dashboard or app interface do Weight
you pay next most attention to? Calories consumed
Steps
Very active minutes
Activity log
Explain. __________________________________
How often do you check your lightly active minutes? Never
Once a week
Several times a week
Every day or more
Explain __________________________________
Do you feel the fitbit provides accurate feedback Yes
about your light activity? No
Explain. __________________________________
How useful was the fitbit feedback in increasing your Not at all useful
light activity? Slightly useful
Moderately useful
Very useful
Explain. __________________________________
How much did tracking your light activity affect your No affect
behavior? Minor affect
Moderate affect
Major affect
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What affect does tracking your TV time have on No affect
decreasing your TV time? Minor affect
Moderate affect
Major affect
Explain. __________________________________
How much easier has the Aria scale made it to track No difference
your weight? Slightly more easy
Moderately more easy
Much more easy
Explain. __________________________________
How easy is it to use the LoseIt account compared to Much less easy
paper tracking? Somewhat less easy
Somewhat more easy
Much more easy
Explain. __________________________________
How much time do you spend using the LoseIt app Much less time
compared to paper tracking? Somewhat less time
Somewhat more time
Much more time
Explain. __________________________________
What changes, if any, would you make to the
technology provided? __________________________________
What changes, if any, would you make to the feedback
provided in the bi-weekly reports Danielle gives
you? __________________________________
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APPENDIX III 
INTERVENTION SESSION SCHEDULES  
AND MAINTENANCE INTERVENTION MATERIALS 
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Session Week of: Topic 
1 6/17/13 Getting Started 
2 6/24/13 Self-Monitoring and Goal Setting 
3 7/1/13 Get Moving to Better Health 
4 7/8/13 Getting the Social Support You Need 
5 7/15/13 Physical Activity and Breast Cancer 
6 7/22/13 Fruits and Veggies: More Matters 
7 7/29/13 Food Labels 
8 8/5/13 Taking Charge of What’s Around You 
9 8/12/13 Nutrition and Breast Cancer 
10 8/19/13 Eating More for Less 
11 8/26/13 How Do You See Yourself? 
12 9/2/13 Pick up the Pace 
13 9/9/13 Smart Shopping & Portion Control 
14 9/16/13 Managing Stress 
15 9/23/13 Eating on the Go 
16 9/30/13 My Plan for Maintenance 
Weekly Schedule 
Weight Loss Phase 
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Phone Group –Four Month Program  
 
Phone Meeting Day/Time 
All meetings are held by conference call on your assigned evening from 5:30 p.m. to 
6:30 p.m. Please call 5-10 minutes early. 
After the first meeting (60-75 minutes), sessions will last about 60 minutes.  
 
Accountability 
You will send in food and exercise reports in the middle and at the end of each week.  
• Reports for ___________ through ___________ are due on ___________ by 10 
a.m.    
• Reports for ___________ through ___________ are due on ___________ by 10 
a.m.  
 
Counselor Contact Information 
Send Reports To: Danielle Christifano       
        Phone: (913) 945-7890      
        Email:  dchristifano@kumc.edu 
 
Every meeting will begin with an opportunity to review diet and exercise behaviors, and 
to discuss challenges and successes since the last session. Your counselor will then 
lead the group in a discussion covering the main lesson for the week. You are always 
encouraged to participate, to ask questions, and to provide support to your group 
members.  
             
Joining Your Group Meeting 
 
You will be able to call in from any phone. 
 
1. Call this number: 1-800-977-8002 
 Because this is an 800 number, you will not have to pay any long distance charges.  
 
2. After you hear the ring, you will hear a recording. When the recording asks for a PIN 
number, enter 2154448#. Do not share this number with anyone outside of the 
group.  
 
3. After entering your PIN number, you will hear a beep. When you hear this beep, you 
know you have joined the call. Your counselor will hear the beep as well, and will 
welcome you to the group.  
 
*If you join before your counselor, you will be put on hold until she dials in. 
*DO NOT call in while driving. 
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Session Date Objective Topic 
1  
 In Person 10/8/13 Nutrition News  My Plate and Meal Planning  
2 10/22/13 Life Lessons Power of Problem Solving 
3 11/5/13 Fitness Flash  Interpreting Accelerometer Data  
4  
In Person 11/19/13 Nutrition News Holiday Planning 
5 12/3/13 Planning and Prevention Acceptance and Commitment  (Guest Speaker) 
6  
In Person 12/17/13 Life Lessons Making Peace with the Scale  
7 12/30/13 (Monday) Fitness Flash Commit to Staying Active 
8  
In Person 1/14/14 Life Lessons  
Mindful Eating  
(Guest Speaker) 
9 1/28/14 Planning and Prevention Eating Out and Regain 
10  
In Person 2/11/14 Fitness Flash  
Fitness and Your Health  
(Guest Speaker) 
11 2/25/14 Nutrition News Decisions, Decisions 
12  
In Person 3/11/14 Nutrition News 
Keeping Nutrition Information in 
Perspective  (Guest Speaker) 
13 3/25/14 Planning and Prevention  Planning for the Future 
10 month testing sessions will be Tuesday, April 1st – Friday, April 4th 
Weekly Schedule 
Weight Maintenance Phase 
144
 
 
Session Date Objective Maintenance Topic 
1  
 In Person 10/10/13 Introduction  Intro to Standing for Better Health 
2 10/24/13 Nutrition News Lightly Active Time & Meal Planning 
3 11/7/13 Fitness Flash  TV Time & Accelerometer Data  
4  
In Person 11/21/13 Nutrition News 
Uninterrupted Sitting  
& Holiday Planning 
5 12/5/13 Life Lessons Power of Problem Solving  
6  
In Person 12/19/13 Planning and Prevention 
Acceptance and Commitment  
(Guest Speaker) 
7 1/2/14 Life Lessons Making Peace with the Scale 
8  
In Person 1/16/14 Life Lessons  
Mindful Eating 
(Guest Speaker)  
9 1/30/14 Planning and Prevention Eating Out and Regain 
10  
In Person 2/13/14 Fitness Flash 
Commit to Being Fit 
(Guest Speaker)   
11 2/27/14 Nutrition News Decisions, Decisions 
12  
In Person 3/13/14 Nutrition News 
Keeping Nutrition Information in 
Perspective (Guest Speaker)  
13 3/27/14 Planning and Prevention  Planning for the Future 
10 month testing sessions will be Tuesday, April 1st – Friday, April 4th 
Weekly Schedule 
Weight Maintenance Phase 
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What is sedentary behavior? 
Sedentary behavior is simply the time you spend 
sitting or reclining throughout your day. These 
activities require little or no energy to do (remember, 
energy = calories).  We have talked a lot about 
calories in foods during phase 1, but we will now 
focus on calories in a new way.  Below is a graph 
that shows you how your body uses calories on a 
daily basis.  
 
 
 
 
 
 
 
Your Resting Metabolic Rate (RMR) is the 
energy your body needs when it is at rest.  
An estimate of RMR can be calculated 
based on your age, sex, weight and height.  
This is what we use to calculate the base for 
your maintenance calorie goals. 
This is the energy you use for all of your 
daily activity– this includes your planned 
physical activity and light, lifestyle activity 
like sitting while talking or watching 
television. You have the most control over 
this portion of your daily energy!      
This is the energy you use for digestion. 
Digestion 
Resting Metabolic 
Rate 
Activity 
0% 
100% 
50% 
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68% 
31% 
1% 
Breast  Cancer Survivors in the US  
Sedentary Light Activity Moderate to Vigorous Activity
Most Americans spend the majority of their “activity” section doing only things that 
involve sitting. Let’s take a closer look at calories burned during activities of daily life.   
 
 
 
 
 
 
 
 
 
 
 
 
 
During this phase of the program you will try to maintain physical activity at 225 minutes 
per week, while replacing sitting time with light activity.    
 
 
 
 
 
 
.  
 
 
 
Home & Daily Life Activities Calories burned per 30 min 
 155 lb person 185 lb person 
Sleeping 23 28 
Watching TV 28 33 
Reading: sitting 42 50 
Standing in line 47 56 
Computer Work 51 61 
Light Office Work 56 67 
Sitting in Meetings 60 72 
Desk Work 65 78 
Cooking 93 111 
Food Shopping: with cart 130 155 
Moving: unpacking 130 155 
Playing w/kids: moderate effort 149 178 
Heavy Cleaning: wash car, windows 167 200 
Leisurely walking  130 155 
Brisk walking 149 178 
Swimming 223 266 
Jogging (5 mph – 12 min/mile) 298 355 
 
Replacing sitting time with other light activities will help you burn 
extra calories throughout your day.  It can also help to improve 
circulation, prevent swollen ankles or feet and help relieve aches and pains.  
 
What else?   
Reducing sitting time has been shown to reduce the risk of heart disease, 
diabetes, cancer, and death. 
 
The average American spends 
over 50% of their waking hours 
sitting and the average breast 
cancer survivor and older adult 
spends approximately 68% of their 
waking hours sitting. 147
What are some common activities that involve sitting for a long period of time? 
________________________   ________________________ 
________________________   ________________________ 
________________________   ________________________ 
 
 
 
How often do you sit? 
1. Are you sitting more now than you did when you were a child? 
2. Are you sitting more now than you did before your breast cancer diagnosis? 
3. Are you sitting more than your parents did at your same age? 
 
Now think about yesterday – List your daily activities on the schedule below: 
6:00 am  3:00 pm  
7:00 am  4:00 pm  
8:00 am  5:00 pm  
9:00 am  6:00 pm  
10:00 am   7:00 pm  
11:00 am   8:00 pm  
12:00 pm   9:00 pm  
1:00 pm   10:00 pm  
2:00 pm  11:00 pm  
 
STRATEGIES TO REDUCE SEDENATARY BEHAVIOR 
 
The following goals will help you to be more active throughout the entire day, not just 
during your planned exercise minutes.  We will discuss each of these three goals in 
more detail throughout the next three sessions.   
 
 
 
 
Place a star 
next to all of 
the activities 
that involve 
sitting 
1. Increase light activity time  
2. Decrease TV time 
3. Limit uninterrupted bouts of sitting to less than 30 minutes 
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During the next 6 months, we will focus on weight loss maintenance and decreasing 
sitting time. Much of what you have done in the first 4 months will remain the same, 
however there will be a few new and exciting elements to add!  Your Fitbit Zip is 
designed to help you to monitor your sitting time.  New technology will be introduced 
during this phase because it will help you to be more aware and becoming more aware 
will help you to change your habits!  
Your group leader will help you set up your accounts and provide you with a password.  
Fitbit Zip 
 
 
 
 
 
 
Aria Smart Scale 
 
 
 
 
 
 
Lose It! Account 
 
 
Your Fitbit Zip will be your new pedometer for 
phase 2.  You will also use your Fitbit account 
online to determine when you spend the most time 
sitting each day of the week.  We will review how 
to do this during the meeting. 
Your Aria Smart Scale will be the scale you weigh 
on during phase 2.  The scale will sync wirelessly 
with your Fitbit account.   
Instead of keeping monthly food diaries on paper, 
you will now log your food through your Lose It 
account.  Your daily calories will also sync with 
your Fitbit account – this means your weight, daily 
calorie intake, steps, and physical activity will all be 
visible in one place!  
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HOW TO LOG IN: You will sign into www.fitbit.com/login and enter the login information 
given to you by your group leader. 
 
 
 
 
 
 
 
 
 
 
 
WHAT YOU WILL SEE:  When you log in to your Fitbit account you will see your 
dashboard.  Your dashboard has been set up specifically for you. Below is an example. 
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WEIGHT: 
Here you will see the weight from your Aria Smart 
Scale.  This weight will wirelessly sync with your 
account – all you need to do is step on the scale! 
 
FOOD PLAN: 
Here you will see how many calories you have 
consumed, compared to how many calories you 
should eat to meet your weight goal.  This will sync 
automatically from your lose it account.   
 
STEPS:  
Here you will see your daily step total.  
 
 
VERY ACTIVE MINUTES: 
Here you will see your daily moderate-vigorous 
intensity physical activity minutes.  
 
 
ACTIVITY:  
You will also see a graph that charts your step 
activity throughout the day.  This is the chart you will 
use to determine what times throughout the day you 
are sitting the most.  
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HOW TO USE LOSE IT! 
STEP ONE: Go to https://wsbh.loseit.com/.  You will enter your email and the password 
assigned to you by your group leader.  
 
  
 
 
 
 
 
 
 
STEP TWO:  You will see your home screen immediately after you log in.  You will click on “Add 
Food” in the upper left hand corner and click the meal you plan to enter.   
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STEP THREE:  Choose from the following options: add an item from your food list, search for a 
new food, add or create a recipe, search for a supermarket food, or search for a restaurant food.    
 
 
 
 
 
 
 
 
 
 
 
 
STEP FOUR:  Enter the serving size of the food.    
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STEP FIVE:  Repeat steps 2-4 until you have added all of your daily intake.  The green bar will 
show you your total calorie intake for the day.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LET’S PRACTICE! 
 
 
 
 
  
 
Your food tracking information will only be visible to you and your 
group leader.  Your daily intake will sync automatically with your 
Fitbit account.  
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1. Attend Meetings: Successful weight managers attend sessions. Motivation can easily slide 
when you do not attend the phone sessions or in-person meetings. 
2. Be Physically Active: Exercise is essential for long-term weight management.  
3. Monitor Your Food, Exercise, Sitting Time: Self-monitoring makes you aware of your eating 
and exercise habits, allows you to evaluate areas of success and failure, and keeps you 
accountable. 
4. Control Your Portions: Oversized portions are everywhere, from restaurants to supermarkets 
to vending machines. One of the keys to maintaining a healthy weight is to control portion sizes. 
5. Eat Fruits and Vegetables: Fruits and vegetables are low in calories, help to fill you up fast, 
and are full of nutrients. They work to crowd out other higher calorie foods in your diet. 
6. Change Your Environment: You will need to continue to change things in your life in order to 
make your new behaviors lifelong habits. 
Each day we recommend the following:  
• At least two of your meals are pre-packaged meals (shakes and/or entrees) 
• At least 5 one-cup servings of fruits and veggies  
• Snacks should consist of only fruits and veggies.   
• Condiments less than 15 calories per tablespoon 
 
Note about Calcium – Remember that the Institute of Medicine recommends that women age 51 
and older get 1200 mg of calcium per day. If you choose to incorporate low-fat dairy products into 
your diet, you may be able to reduce your calcium supplementation to 500-600 mg per day.  
Self-Monitoring:  You will continue to send in your weekly data form once per week.  You will keep 
a food diary via your Lose It account every day.   
Exercise:  The exercise goal is still 225 minutes of aerobic activity each week or more.  
Sitting Time:  We will focus on a new goal to reduce sitting time for the next three sessions.   
 
What should I do to succeed at maintenance? 
What are the diet, exercise and sitting time recommendations?  
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Now that you have had a chance to use your new devices, we will focus on how you will 
use your Fitbit to set goals to reduce your sitting time.   The next three sessions will 
each focus on a new goal.  Today we will focus on the first goal – increase light activity 
time! 
 
 
 
 
 
 
Goal One:  Increase light activity by an average of 30 minutes per day after the first two 
weeks. If you meet your goal for a two week period, you will increase your average 
lightly active minutes by an average of 15 minutes per day for the next two weeks.  If 
you do not meet your goal, you can keep the same goal for the next two weeks. Your 
group leader will help you determine your goals each two week period.  
 
 
 
The act of standing up requires your large muscles to engage, specifically your 
quadriceps and core muscles.  Muscle engagement requires calories, so the more 
standing you do, the more calories you burn.  On the flip side, sitting for too long causes 
your muscles to enter a sort of hibernation mode.  Your muscles stop using calories and 
stop producing key enzymes used to regulate metabolism.  Bottom line is sitting too 
long and too often can be detrimental to your health.   
 
In fact, recent research from dozens of studies suggests the more time you spend 
sitting, the higher your risk for:   
• Obesity   
• Type 2 diabetes 
• Heart disease 
• Metabolic syndrome 
• Cancer 
• Mortality 
 
Interestingly,  these relationships hold true even for those people who exercise on a 
regular basis.  Through our own research among breast cancer survivors, we found 
women tend to increase their physical activity minutes while simultaneously increasing 
their sitting time.  Have you ever finished a work out and thought, “Great! I completed 
my exercise for the day – now it’s time to sit down and relax” ??  This is not the case!  
Standing up and moving around throughout the day may be just as important as 
exercise.    
1. Increase light activity time  
2. Reduce TV time 
3. Limit uninterrupted bouts of sitting to less than 30 minutes 
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Look at the graph below.  The “Inactive” bars are those people who exercise less than 
150 minutes per week and the “Active” bars are those people who exercise at least 150 
minutes per week.  The vertical axis represents death rates.  Each color indicates 
varying levels of sitting time.  You will notice the rate of death increases as sedentary 
time increases for both people meeting exercise recommendations of 150 minutes per 
week and people who are not.      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Every two weeks you will get a report from your group leader stating your activity 
averages over the past two weeks – including your minutes sedentary and your minutes 
lightly active.  On your activity report, you will also see a graph of your activity averages 
over the past 4 weeks.  This will help you to gauge your own progress.  Lastly, you will 
see your goal for lightly active minutes for the next two weeks.  
 
On your activity worksheet you will see a summary of your minutes sedentary (including 
sleeping), minutes lightly active, minutes fairly active and minutes very active. Let’s 
review what counts toward each activity level.  Keep in mind this will vary slightly based 
on the individual.  
 
 Activity Level Examples 
Sedentary Sitting, reclining, laying down, sleeping 
Lightly Active Walking at a leisurely pace (e.g. light house work: dusting, 
sweeping, dishes, cooking)  
Fairly Active Walking at a quicker pace (e.g. mowing the lawn, moderate house 
work: mopping, vacuuming, scrubbing floors) 
Very Active Any activity that  causes you to  break a sweat (e.g. brisk walking, 
jogging, running)  
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Katzmarzyk PT, Church TS, Craig CL, Bouchard C. Sitting time and mortality from all causes, cardiovascular disease, and cancer. 
Medicine and science in sports and exercise 2009;41(5):998-1005. doi: 10.1249/MSS.0b013e3181930355. 
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Date Day Weight Steps 
Minutes 
Sedentary 
(includes 
sleeping) 
Minutes 
Lightly 
Active 
Minutes 
Fairly 
Active 
Minutes 
Very Active 
10/7/2013 Mon 180.00 12,890 1,202 68 35 135 
10/8/2013 Tues 180.20 10,108 1,312 78 10 40 
10/9/2013 Wed 180.10 2,919 1,100 162 30 148 
10/10/2013 Thurs 179.80 4,155 1,235 80 85 40 
10/11/2013 Fri 179.90 6,836 1,255 97 48 40 
10/12/2013 Sat 179.50 10,304 989 225 185 41 
10/13/2013 Sun 179.80 14,903 1,002 70 152 216 
10/14/2013 Mon 180.00 12890 1,080 200 80 80 
10/15/2013 Tues 180.20 10,108 1,100 120 180 40 
10/16/2013 Wed 180.10 2,919 1,240 65 95 40 
10/17/2013 Thurs 179.80 4,155 956 180 125 179 
10/18/2013 Fri 179.90 6,836 1,069 150 200 21 
10/19/2013 Sat 179.50 10,304 989 102 115 234 
10/20/2013 Sun 179.80 14,903 1,020 60 80 280 
Average   8,874 1,111 118 101 110 
    18.5 hrs 2.0 hrs 1.7 hrs 1.8 hrs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Example Goal for 11/4 – 11/18  
Average 2 hours 30 minutes (150 minutes) of lightly active minutes per day 
 
18.5 
19.5 
2 
1.5 
1.7 
1.5 
1.8 
1.5 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
10/21-11/4
10/7-10/21
Activity Averages Per Day  
Hours Sedentary (includes sleeping) Hours Lightly Active
Hours Fairly Active Hours Very Active
EXAMPLE 
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Monitoring your Daily Lightly Active Time:  
Step One:  Log in to your Fitbit account. 
Step Two:  Click on the “Expand” magnifying glass on the “Very Active Minutes” Tile of 
your dashboard. 
 
 
 
 
 
 
 
Step Three:  Your activity over the past month will appear. Click on the “All” option on 
the upper right.   
 
 
 
 
 
 
Step Four: Hover your mouse over the day that you will like to see.  And write down the 
minutes in red – these are your lightly active minutes.  
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Take a look at your “Activity” tile on your Fitbit dashboard.   Below you will see an example of 
Sally’s Activity Tiles from a work day and non-work day.   Notice how her work day included 
exercise in the morning, but the remainder of her day was spent sitting.   On her non-work day, 
Sally was much more active throughout the day with fewer bouts of sitting.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When are you sitting the most on work and non-work days?  
Work Days Non-Work Days 
  
 
Example Work Day 
Example Non-Work Day 
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In Phase 1 we discussed the role stress plays in your weight management journey and how it is 
important to find positive ways to cope and reduce stress levels.  Taking time to unwind is one 
such technique that is very important for stress management. Often times people associate their 
relaxation or  enjoyment time with sitting time.  First think of a few of your major stressors 
and ask yourself, could I do a standing activity to help reduce this stress? If not, that’s 
okay!  We do not want you to cut your relaxation time you cherish the most, but the goal is to 
determine which activities are worth it and which could be spent  in other ways. List a few of 
the activities you look forward to most in your day that help you unwind. Then list the 
average time you spend doing each activity, and ask yourself is it worth it?   
Activity Average time spent Is it worth it? 
   
   
   
   
 
 
 
 
Let’s review a few strategies to help you meet your light activity goals!  Below are a few 
examples and space for you to add your own ideas.   
1. Replace sitting activities with light activities.   
• Fold laundry while standing 
• Stand up while reading rather than sitting down 
• Shop at stores rather than shopping online 
• Stand up and walk around when talking on the phone at home or when socializing at 
social gatherings  
• Stand up while doing arts and crafts such as sewing or quilting  
• Stand up while doing crossword puzzles or other games 
•  Take a shower instead of a bath 
• __________________________________________________________________ 
• __________________________________________________________________ 
• __________________________________________________________________ 
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2. Add new hobbies and chores to your daily routine that are more active 
• Walk with friends or a pet 
• Walk to the park with your kids or grandkids  
• Play with pets – either your own, others’ pets, or at a pet store 
• Ride your bike for short trips to the grocery store 
• Dance  
• Work in the garden 
• Complete home improvement projects you’ve been wanting to do 
• Rake leaves or shovel snow  
• Cook or bake healthy recipes 
• Deliver notes or meals to neighbors by walking to their homes 
• Volunteer at a local charity 
• __________________________________________________________________ 
• __________________________________________________________________ 
• __________________________________________________________________ 
 
 
3. Add more standing into your work day routine 
• Hold walking or standing meetings 
• Move your computer to a higher surface so you can stand and type 
• Stand when you are on the phone 
• Drink more water so you have to walk to the restroom more often 
• Drink from a smaller glass so you have to refill it more often 
• Instead of sending an email or calling your co-workers, walk to their office 
• __________________________________________________________________ 
• __________________________________________________________________ 
• __________________________________________________________________ 
 
 
4. General suggestions to increase light activity 
• When you have to recycle an item, walk to your garage to throw the item away 
• Walk outside to retrieve the mail instead of driving 
• Drive less and participate in more carpools 
• Go for more walks – for both transportation and recreation purposes 
• Take the stairs instead of the elevator 
• Park further away from your destination 
• Walk to any of your errands that are only a short distance away (e.g. grocery store, 
pharmacy, bank)   
• __________________________________________________________________ 
• __________________________________________________________________ 
• __________________________________________________________________ 
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Goal TWO: Reduce TV time to less than 90 minutes per day and replace TV time 
with light activity.   
 
Using a TV log will be helpful in counting your TV time.  You can leave a copy of this log 
next to your couch or TV for the next week.  Every time you sit down to watch to TV, 
you should write the start time and the stop time.  You should also rate your enjoyment 
from 1-10 (1 = no enjoyment and 10 = maximum enjoyment).  Each week, you will fill in 
your daily TV time goal and track your actual TV time on your weekly data form. There 
are more copies of this log in the back of your binder.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Increase light activity time  
2. Reduce TV time 
3. Limit uninterrupted bouts of sitting to less than 30 minutes 
Day Programs Watched 
Were 
you 
Sitting? 
Start 
Time 
Stop 
Time 
Total TV 
Time 
Rate Enjoyment 
(1-10) 
Example 
Good Morning America 
Jeopardy 
No 
Yes 
6:30am 
5:00 pm 
7:15am 
6:00 pm 
45 minutes 
60 minutes 
4 
8 
Monday       
Tuesday       
Wednesday       
Thursday       
Friday       
Saturday       
Sunday       
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Did you know that the average American spends over 2 hours per day watching 
television? In fact, after work and sleep,  TV time is the most commonly reported activity 
among Americans.  There is substantial evidence that all of this TV time is not helping  
America’s waist line.  Several reasons for the link between TV time and obesity are 
listed below: 
• TV time encourages more sitting and results in less calories burned throughout 
the day. 
• TV time promotes more unhealthy snacking and mindless eating. 
• TV time leaves less time for exercise and light activities.  
Let’s take a look at the research… 
In a study reporting TV time and mortality rates among over 200,000 Americans, the 
people who reported the most television viewing (more than 7 hours per day) were at 
the greater risk for heart disease, cancer and death when compared to those people 
who watched less than one hour per day of television.  The graph below shows the 
relative risk of dying based on hours of TV watched per day.  Watching more television 
was associated with greater likelihood of death for all groups, including those who 
exercise a lot and those who do not exercise.  
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Matthews CE, George SM, Moore SC, et al. Amount of time spent in sedentary behaviors and cause-specific mortality in US adults. The 
American journal of clinical nutrition 2012;95(2):437-45. doi: 10.3945/ajcn.111.019620. 
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What kind of TV watcher are you? 
A.  Channel Surfer 
B. Weekends only 
C. Morning news 
D. Background  
E. DVR only  
F. Other  
Where do you watch the most TV? 
A. In the family room/living room 
B. In the bedroom/in bed 
C. In the kitchen  
D. Other  
What is your favorite show?  _____________________________________________ 
Do you crave certain foods when you watch TV? ____________________________ 
 
 
 
 
• Be  more selective about what to watch 
• Rather than channel surfing, turn the TV on only for specific programs 
• Make some days of the week TV-free days 
• Cancel your cable subscription, or reduce the number of channels you receive 
• Stop watching TV at dinner and other meal times 
• Have only one TV in the house, or have only one designated room in the house 
for television watching even if there are other TVs around 
• If you can, record the show and fast-forward through commercials  
• Keep a timer near your TV and turn the television off when the timer goes off 
• Keep a log near the television and document how much time is spent watching 
television 
• ________________________________________________________________ 
• ________________________________________________________________ 
• ________________________________________________________________ 
• ________________________________________________________________ 
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Now that you have had practice reducing your overall sitting time, we will focus on 
identifying the time periods each day when you sit the longest without getting up at all. 
You will only be asked to monitor your uninterrupted sitting time a few times throughout 
phase two.   
 
Goal 2: Stand up and move after 30 minutes of uninterrupted sitting.  
 
You will use your activity summaries from your Fitbit dashboard to determine when you 
do the most uninterrupted sitting.   You should sign into your Fitbit account at the end of 
each day this week and view the “Activity” tile on your dashboard.  You will identify all of 
the “blank” periods of time (the periods of time with no bars) throughout your day lasting 
longer than 30 minutes. Think about what activities you were doing during each 30 
minute period of uninterrupted sitting.   
For example, in the graph below, this person was sitting from 10am -11am, 1pm – 
2:30pm, 5pm-6:30pm, and from 8pm-9pm.   
 
 
 
 
 
 
 
 
 
 
 Sitting bouts longer than 30 minutes 
1. Increase light activity time  
2. Reduce TV time 
3. Limit uninterrupted bouts of sitting to less than 30 minutes 
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Sitting 
Driving 
Watching 
TV 
Eating 
Computer 
time 
Socializin
g  
Working 
Think about your day. Chances are it probably includes 
several, if not all of the items listed to the right.  Our days 
revolve around sitting.  In fact, most Americans spend over 
half of their waking hours sitting.   (I bet you are sitting as 
we review this session!) 
Breaking up your sitting time with short bouts of standing 
has been shown to improve the body’s ability to regulate 
blood sugar and insulin levels.  Controlled studies have 
examined the effects of breaking up prolonged sitting time 
every 20 minutes with leisurely or brisk walking over a 4 
hour period.  The groups that got up every 20 minutes after 
a meal had lower glucose and insulin levels than the group 
that sat the entire time.   This is very important for breast 
cancer survivors given the association between insulin and 
recurrence.  
Taking a “standing break” can also help to improve blood 
circulation, prevent swollen ankles and feet, and assist in 
the management of muscle aches and pain. 
 Take a look at your “Activity” tile on your Fitbit Dashboard.  When are you sitting 
uninterrupted the most? 
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________ 
_____________________________________________________________________________ 
What do you need to focus on during long uninterrupted bouts of sitting? 
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________ 
_____________________________________________________________________________ 
How can you interrupt your sitting time while still being able to sustain needed attention? 
How can you set up your own reminder system? 
_____________________________________________________________________________
_____________________________________________________________________________
_____________________________________________________________________________ 
_____________________________________________________________________________ 
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Common activities Strategies 
Watching TV 
• Stand up and do something different during advertisements 
• Put the remote control by the TV 
• ______________________________________________ 
Reading 
• Get up and walk between chapters 
• Organize a desk drawer or closet or (un)pack a box in between 
chapters 
• Stand while reading for every other chapter 
• ______________________________________________ 
Computer Use  
(at home) 
• Listen to music and stand up after each song 
• Stand up after each e-mail you send 
• Stand up and walk around after each game you play 
• ______________________________________________ 
Computer Use  
(at work) 
• Set an alarm on your computer to remind you to stand every 30 
minutes 
• Use an app like Fitbolt.com or Workrave.com to remind you to 
get up and move. 
• ______________________________________________ 
 
Socializing 
• Offer to get other family members food/refreshments 
• ______________________________________________ 
• ______________________________________________ 
 
Hobbies 
• Listen to music and stand up after each song 
• ______________________________________________ 
• ______________________________________________ 
 
Driving  
• Start a car pool for your children so you can spend less time 
driving.   
• Rearrange driving schedule to drive less  
• ______________________________________________ 
 
 
• ______________________________________________ 
• ______________________________________________ 
 
 
• ______________________________________________ 
• ______________________________________________ 
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Day Time Frame Sitting Activity Strategy to Change 
Example 
10am-11am 
1pm-2:30pm 
5pm-6pm 
8pm-9:30pm 
Working at computer 
Eating lunch/socializing 
Eating dinner/family time 
Watching TV 
Set alarm for 30 minutes 
After eating, stand up to socialize 
After eating, suggest a family walk 
Stand up during commercial breaks 
Monday    
Tuesday    
Wednesday    
Thursday    
Friday    
Saturday    
Sunday     
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Dates: My Goal Mon Tues Wed Thurs Fri Sat Sun 
Fruits /day 
Veggies /day 
Shakes /day 
Entrées /day 
Meals Out 
Unplanned 
Snacks 
Exercise 
Min 
_____min    _____ times per week 
Lightly 
Active Min 
Weekdays: 
Weekends: 
TV Time Min 
Weekdays: 
Weekends: 
NAME: 
Did you meet your diet goal? Yes  /  No 
Did you meet your exercise minutes goal? Yes  /  No 
Did you meet your lightly active minutes goal?  Yes  /  No 
Did you meet your TV time minutes goal?  Yes  /  No 
What barriers did you encounter while trying to meet you goals? 
Were your goals too high?   
What will you change for next week? 
Have you had any changes to your health or medications? 
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